{
  "letters": 559523,
  "pages": 133,
  "meta": {
    "end_of_period": {
      "year": 2022,
      "month": 12
    },
    "company_name": "HCA Healthcare, Inc.",
    "major_industry": "Healthcare",
    "mentions_recent_mergers_and_acquisitions": {
      "value": true,
      "elements": [
        {
          "type": "merger_acquisition",
          "page": 3,
          "title": "Financial Performance Overview and Shareholder Communication",
          "data": [
            {
              "key": "total_revenue_2022",
              "value": "$60.2 billion"
            },
            {
              "key": "increase_in_revenue",
              "value": "2.5% from 2021"
            },
            {
              "key": "cash_flows_from_operations",
              "value": "$8.5 billion"
            },
            {
              "key": "share_repurchased",
              "value": "$7 billion (over 30 million shares)"
            },
            {
              "key": "dividend_increase",
              "value": "17% over 2021"
            },
            {
              "key": "pre_tax_proceeds_from_divestitures",
              "value": "over $1.2 billion"
            },
            {
              "key": "taxes_incurred",
              "value": "approximately $5.6 billion (including $2.3 billion of income, property, and sales and use taxes)"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "merger_acquisition",
          "page": 8,
          "title": "Trading Symbol and Exchange Listing",
          "data": [
            {
              "key": "Trading Symbol",
              "value": "HCA"
            },
            {
              "key": "Name of Each Exchange",
              "value": "New York Stock Exchange"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "merger_acquisition",
          "page": 113,
          "title": "Acquisitions and Dispositions Summary",
          "data": [
            {
              "key": "Acquisition Amount (2022)",
              "value": "$224 million"
            },
            {
              "key": "Acquisition Amount (2021)",
              "value": "$67 million to acquire hospital facilities, $594 million for urgent care centers, $114 million for other non-hospital entities"
            },
            {
              "key": "Acquisition Amount (2020)",
              "value": "$568 million for a hospital and other entities"
            },
            {
              "key": "Purchase Price Excess (2022)",
              "value": "$262 million"
            },
            {
              "key": "Purchase Price Excess (2021)",
              "value": "$1.002 billion"
            },
            {
              "key": "Purchase Price Excess (2020)",
              "value": "$279 million"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "merger_acquisition",
          "page": 114,
          "title": "NOTE 3 — ACQUISITIONS AND DISPOSITIONS & NOTE 4 — INCOME TAXES",
          "data": [
            {
              "key": "2022_real_estate_sales_proceeds",
              "value": "$326 million"
            },
            {
              "key": "2022_real_estate_pretax_gain",
              "value": "$274 million"
            },
            {
              "key": "2022_real_estate_after_tax_gain",
              "value": "$200 million"
            },
            {
              "key": "2022_controlling_interest_sales_proceeds",
              "value": "$911 million"
            },
            {
              "key": "2022_controlling_interest_pretax_gain",
              "value": "$1.027 billion"
            },
            {
              "key": "2022_controlling_interest_after_tax_gain",
              "value": "$527 million"
            },
            {
              "key": "2021_hospital_facilities_sales_proceeds",
              "value": "$1.502 billion"
            },
            {
              "key": "2021_hospital_facilities_pretax_gain",
              "value": "$1.226 billion"
            },
            {
              "key": "2021_hospital_facilities_after_tax_gain",
              "value": "$920 million"
            },
            {
              "key": "2021_other_investments_sales_proceeds",
              "value": "$658 million"
            },
            {
              "key": "2021_other_investments_pretax_gain",
              "value": "$394 million"
            },
            {
              "key": "2021_other_investments_after_tax_gain",
              "value": "$294 million"
            },
            {
              "key": "2020_hospital_facility_sales_proceeds",
              "value": "$68 million"
            },
            {
              "key": "2020_hospital_facility_pretax_loss",
              "value": "$7 million"
            },
            {
              "key": "2020_hospital_facility_after_tax_loss",
              "value": "$9 million"
            },
            {
              "key": "income_tax_state_values",
              "value": "State taxes (in millions): 2022 = 206, 2021 = 311, 2020 = 126"
            },
            {
              "key": "income_tax_federal_values",
              "value": "Federal taxes (in millions): 2022 = 261, 2021 = 24, 2020 = (73)"
            },
            {
              "key": "income_tax_total_amounts",
              "value": "Totals: $2,112 million (2021), $1,043 million (2020)"
            },
            {
              "key": "income_tax_effective_rate_range",
              "value": "Effective tax rates ranged from 19.2% to 23.6% across periods"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "merger_acquisition",
          "page": 116,
          "title": "Earnings Per Share Calculation Details",
          "data": [
            {
              "key": "Net income attributable to HCA Healthcare, Inc.",
              "value": "5,643"
            },
            {
              "key": "Weighted average common shares outstanding",
              "value": "290.348"
            },
            {
              "key": "Effect of dilutive incremental shares",
              "value": "4.318"
            },
            {
              "key": "Shares used for diluted earnings per share",
              "value": "294.666"
            },
            {
              "key": "Basic earnings per share",
              "value": "19.43"
            },
            {
              "key": "Diluted earnings per share",
              "value": "19.15"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "merger_acquisition",
          "page": 116,
          "title": "Debt Securities and Money Market Funds Analysis",
          "data": [
            {
              "key": "Debt securities Money market funds and other",
              "value": "473"
            },
            {
              "key": "Amortized cost",
              "value": "511"
            },
            {
              "key": "Unrealized gains",
              "value": "0"
            },
            {
              "key": "Unrealized losses",
              "value": "-38"
            },
            {
              "key": "Amounts classified as current assets",
              "value": "-92"
            },
            {
              "key": "Investment carrying value",
              "value": "381"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "merger_acquisition",
          "page": 116,
          "title": "Debt Securities Valuation and Fair Value Analysis",
          "data": [
            {
              "key": "Debt securities, Money market funds and other.",
              "value": "125"
            },
            {
              "key": "Total Amortized Cost",
              "value": "525"
            },
            {
              "key": "Gains",
              "value": "18"
            },
            {
              "key": "Losses",
              "value": "-2"
            },
            {
              "key": "Fair Value",
              "value": "541"
            },
            {
              "key": "Amounts classified as current assets",
              "value": "-103"
            },
            {
              "key": "Investment carrying value",
              "value": "438"
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_leadership_changes": {
      "value": true,
      "elements": [
        {
          "type": "leadership_change",
          "page": 7,
          "title": "Leadership Changes and Organizational Restructuring Announcement",
          "data": [
            {
              "key": "Scholarship Investments",
              "value": "$1.55 million to Tennessee State University for scholarships for healthcare and computer science; $1.5 million to Fisk University for support in an accelerated dual-degree program with Galen College of Nursing"
            },
            {
              "key": "Philanthropic Gifts",
              "value": "Approximately $6.75 million in gifts since 2021 as part of a three-year $10 million pledge to HBCUs/HSIs"
            },
            {
              "key": "Sustainability Governance",
              "value": "Robust governance measures in place to ensure sustainability strategies, including reducing carbon emissions, are executed"
            },
            {
              "key": "Organizational Changes",
              "value": "Effective January 1, 2023, new operating model includes creation of a chief operating officer role, additional senior vice president-finance, and restructuring into three operating groups with five domestic divisions; aimed at better alignment with strategy and improved long-term performance"
            },
            {
              "key": "Leadership Appointments",
              "value": "Thomas F. Frist III as Chairman of the Board; Samuel N. Hazen as Chief Executive Officer"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "leadership_change",
          "page": 38,
          "title": "Executive Leadership and Management Team",
          "data": [
            {
              "key": "Name",
              "value": "Samuel N. Hazen"
            },
            {
              "key": "Position",
              "value": "Chief Executive Officer and Director"
            },
            {
              "key": "Tenure",
              "value": "January 2019 - Present"
            },
            {
              "key": "Previous Positions",
              "value": "President and COO, President - Operations, President - Western Group, Chief Financial Officer - Western Group"
            },
            {
              "key": "Name",
              "value": "Erol R. Akdamar"
            },
            {
              "key": "Position",
              "value": "President — American Group"
            },
            {
              "key": "Tenure",
              "value": "January 1, 2023 - Present"
            },
            {
              "key": "Previous Positions",
              "value": "President of North Texas Division, CEO of Medical City Dallas Hospital, CEO of St. David's South Austin Medical Center"
            },
            {
              "key": "Name",
              "value": "Jennifer L. Berres"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Chief Human Resources Officer"
            },
            {
              "key": "Tenure",
              "value": "November 1, 2019 - Present"
            },
            {
              "key": "Previous Positions",
              "value": "Vice President — Human Resources"
            },
            {
              "key": "Name",
              "value": "Phillip G. Billington"
            },
            {
              "key": "Position",
              "value": "Senior Vice President — Internal Audit Services"
            },
            {
              "key": "Tenure",
              "value": "January 1, 2019 - Present"
            },
            {
              "key": "Previous Positions",
              "value": "Vice President — Corporate Internal Audit"
            },
            {
              "key": "Name",
              "value": "Jeff E. Cohen"
            },
            {
              "key": "Position",
              "value": "Senior Vice President — Government Relations"
            },
            {
              "key": "Tenure",
              "value": "October 1, 2019 - Present"
            },
            {
              "key": "Previous Positions",
              "value": "20 years with Federation of American Hospitals, Executive Vice President of Public Affairs"
            },
            {
              "key": "Name",
              "value": "Michael S. Cuffe, M.D."
            },
            {
              "key": "Position",
              "value": "Executive Vice President and Chief Clinical Officer"
            },
            {
              "key": "Tenure",
              "value": "January 1, 2022 - Present"
            },
            {
              "key": "Previous Positions",
              "value": "President — Physician Services Group, Vice President of the Company, roles at Duke University Health System"
            },
            {
              "key": "Name",
              "value": "Jon M. Foster"
            },
            {
              "key": "Position",
              "value": "Executive Vice President and Chief Operating Officer"
            },
            {
              "key": "Name",
              "value": "Richard A. Hammett"
            },
            {
              "key": "Position",
              "value": "President — Atlantic Group"
            },
            {
              "key": "Name",
              "value": "Michael A. Marks"
            },
            {
              "key": "Position",
              "value": "Senior Vice President — Finance"
            },
            {
              "key": "Name",
              "value": "Michael R. McAlevey"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Chief Legal Officer"
            },
            {
              "key": "Name",
              "value": "Timothy M. McManus"
            },
            {
              "key": "Position",
              "value": "President — National Group"
            },
            {
              "key": "Name",
              "value": "Sammie S. Mosier"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Chief Nurse Executive"
            },
            {
              "key": "Name",
              "value": "P. Martin Paslick"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Chief Information Officer"
            },
            {
              "key": "Name",
              "value": "Deborah M. Reiner"
            },
            {
              "key": "Position",
              "value": "Senior Vice President — Marketing and Communications"
            },
            {
              "key": "Name",
              "value": "William B. Rutherford"
            },
            {
              "key": "Position",
              "value": "Executive Vice President and Chief Financial Officer"
            },
            {
              "key": "Name",
              "value": "Joseph A. Sowell, Il"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Chief Development Officer"
            },
            {
              "key": "Name",
              "value": "Kathryn A. Torres"
            },
            {
              "key": "Position",
              "value": "Senior Vice President — Payer Contracting and Alignment"
            },
            {
              "key": "Name",
              "value": "Kathleen M. Whalen"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Chief Ethics and Compliance Officer"
            },
            {
              "key": "Name",
              "value": "Christopher F. Wyatt"
            },
            {
              "key": "Position",
              "value": "Senior Vice President and Controller"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "leadership_change",
          "page": 39,
          "title": "Leadership Changes and Appointments",
          "data": [
            {
              "key": "Jon M. Foster",
              "value": "Appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Previously served as President — American Group (January 2013 - December 2022), President — Southwest Group (February 2011 - January 2013), Division President for the Central and West Texas Division (January 2006 - February 2011), and as President and CEO of St. David’s HealthCare in Austin, Texas (March 2001 - February 2011). Prior roles also include executive positions at Baptist Health System and The Methodist Hospital System."
            },
            {
              "key": "Richard A. Hammett",
              "value": "Appointed President — Atlantic Group effective January 1, 2023. Previously served as President of the North Florida Division (June 2020 - December 2022) and held various leadership roles including CEO positions at Swedish Medical Center and other HCA Healthcare facilities."
            },
            {
              "key": "Michael A. Marks",
              "value": "Appointed Senior Vice President — Finance effective January 1, 2023. Previously served as Vice President — Financial Operations Support (March 2021 - December 2022), CFO of the National Group (December 2008 - February 2021), and CFO of the West Florida Division (January 2006 - November 2008). Joined HCA Healthcare in 1996."
            },
            {
              "key": "Michael R. McAlevey",
              "value": "Appointed Senior Vice President and Chief Legal Officer in January 2022. Prior to joining HCA, held senior legal and executive roles at General Electric, including Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018, and other significant legal roles at GE and the SEC."
            },
            {
              "key": "Timothy M. McManus",
              "value": "Appointed President — National Group effective January 1, 2023. Previously served as President of the Capital Division (August 2016 - December 2022) and held CEO roles at Chippenham and Johnston-Willis Medical Center, Reston Medical Center, and Garden Park Medical Center."
            },
            {
              "key": "Sammie S. Mosier",
              "value": "Appointed Senior Vice President and Chief Nurse Executive effective December 1, 2021. Joined HCA in 1992 as a medical-surgical bedside nurse and progressed through various leadership roles including Vice President and Assistant Chief Nursing Executive — Clinical Services Group (2019 - 2021)."
            },
            {
              "key": "P. Martin Paslick",
              "value": "Appointed Senior Vice President and Chief Information Officer in June 2012. Previously served as Vice President and Chief Operating Officer of Information Technology & Services (March 2010 - May 2012) and in other vice president roles within the IT & Services department since joining the Company in 1985."
            },
            {
              "key": "Deborah M. Reiner",
              "value": "Appointed Senior Vice President — Marketing and Communications in October 2017. Previously served as Vice President of Marketing and Customer Relationship Management (with tenures from January 2012 to October 2017) and held roles within the Company’s Mountain Division since joining in 2000."
            },
            {
              "key": "William B. Rutherford",
              "value": "Serving as Executive Vice President and Chief Financial Officer since January 2014. Previously served as Chief Operating Officer of the Clinical and Physician Services Group (January 2011 - January 2014), CFO of the Outpatient Services Group (November 2008 - January 2011), and held several other key financial and operational roles within the Company dating back to 1986."
            },
            {
              "key": "Joseph A. Sowell, III",
              "value": "Appointed as Senior Vice President and Chief Development Officer in December 2009. Previously was a partner at the law firm Waller Lansden Dortch & Davis specializing in health care law, mergers and acquisitions, joint ventures, and private equity."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "leadership_change",
          "page": 40,
          "title": "Leadership Appointments and Changes",
          "data": [
            {
              "key": "Kathryn A. Torres",
              "value": "Appointed Senior Vice President — Payer Contracting and Alignment (formerly Senior Vice President — Employer and Payer Engagement) in July 2016. Joined HCA in 1993 and held various roles including Vice President of Employer and Payer Engagement and Vice President — Strategy."
            },
            {
              "key": "Kathleen M. Whalen",
              "value": "Appointed Senior Vice President and Chief Ethics and Compliance Officer effective January 1, 2019. Previously served as Vice President — Ethics and Compliance (Aug 2013–Dec 2018) and Assistant Vice President — Ethics and Compliance Program Development (Mar 2000–Jul 2013), and worked as Associate Counsel to President Clinton."
            },
            {
              "key": "Christopher F. Wyatt",
              "value": "Appointed Senior Vice President and Controller in April 2016. Previously served as Vice President and Chief Financial Officer for IT&S and Clinical Services Group, and held various positions at Ernst & Young LLP from 2000 to 2010."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "leadership_change",
          "page": 96,
          "title": "Document Signatures and Titles",
          "data": [
            {
              "key": "signature",
              "value": "Samuel N. Hazen"
            },
            {
              "key": "title",
              "value": "Chief Executive Officer and Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "notes",
              "value": "(Principal Executive Officer)"
            },
            {
              "key": "signature",
              "value": "/S/ WILLIAM B. RUTHERFORD"
            },
            {
              "key": "title",
              "value": "Executive Vice President and (Principal Financial Officer and Principal Accounting Officer)"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__Tuomas F. Frist Il Thomas F. Frist III"
            },
            {
              "key": "title",
              "value": "Chairman and Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__Mec G. CROFTON Meg G. Crofton"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__Ropert J. DENNIS Robert J. Dennis"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__NaNcy-ANN DEPARLE Nancy-Ann DeParle"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__ WILLIAM R. FRIST William R. Frist"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/ CHARLES O. HOLLIDAY, JR. Charles O. Holliday, Jr."
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__Huau F. JOHNSTON Hugh F. Johnston"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__MIcHAEL W. MICHELSON Michael W. Michelson"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__ Wayne J. RILEY Wayne J. Riley"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            },
            {
              "key": "signature",
              "value": "/S/__ANDREA B. SMITH"
            },
            {
              "key": "title",
              "value": "Director"
            },
            {
              "key": "date",
              "value": "February 7, 2023"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "leadership_change",
          "page": 129,
          "title": "Certification Pursuant to 18 U.S.C. Section 1350",
          "data": [
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Form",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year End",
              "value": "December 31, 2022"
            },
            {
              "key": "CEO Name",
              "value": "Samuel N. Hazen"
            },
            {
              "key": "CFO Name",
              "value": "William B. Rutherford"
            },
            {
              "key": "Certification Date",
              "value": "February 17, 2023"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "leadership_change",
          "page": 131,
          "title": "Current Leadership of HCA Healthcare",
          "data": [
            {
              "key": "Chairman",
              "value": "Thomas F. Frist Ill"
            },
            {
              "key": "Founder and Managing Principal",
              "value": "Frist Capital"
            },
            {
              "key": "Chief Executive Officer",
              "value": "Samuel N. Hazen"
            },
            {
              "key": "Retired President",
              "value": "Meg G. Crofton"
            },
            {
              "key": "Executive Officers",
              "value": "Samuel N. Hazen, Erol R. Akdamar, Jennifer L. Berres, Phillip G. Billington, Jeff E. Cohen, Michael S. Cuffe, M.D., Jon M. Foster, Robert J. Dennis, Nancy-Ann DeParle, William R. Frist, Charles O. Holliday, Jr, Richard A. Hammett, Michael A. Marks, Michael R. McAlevey, Timothy M. McManus, Sammie S. Mosier, P. Martin Paslick, Deborah M. Reiner"
            },
            {
              "key": "Directors",
              "value": "Hugh F. Johnston, Michael W. Michelson, Wayne J. Riley, M.D., M.B.A., Andrea B. Smith, William B. Rutherford, Joseph A. Sowell, III, Kathryn A. Torres, Kathleen M. Whalen, Christopher F. Wyatt"
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_layoffs": {
      "value": true,
      "elements": [
        {
          "type": "layoff",
          "page": 37,
          "title": "Labor Matters and Employment Challenges",
          "data": [
            {
              "key": "regulatory_laws",
              "value": "subject to various state and federal laws that regulate wages, hours, benefits and employment conditions"
            },
            {
              "key": "union_representation",
              "value": "certain employees at 37 domestic hospitals are represented by labor unions"
            },
            {
              "key": "union_elections_2022",
              "value": "No union elections occurred at any domestic facilities in 2022"
            },
            {
              "key": "union_elections_2023",
              "value": "No elections are scheduled, but future unionization is possible"
            },
            {
              "key": "work_stoppages",
              "value": "No significant work stoppages have materially affected the business"
            },
            {
              "key": "physician_role",
              "value": "integral in delivering quality care; both employed and contracted physicians"
            },
            {
              "key": "labor_costs",
              "value": "increasing labor costs and turnover rate"
            },
            {
              "key": "nurse_shortages",
              "value": "shortages affecting business negatively including capacity issues"
            },
            {
              "key": "initiatives_to_improve_retention",
              "value": "implemented recruiting and compensation initiatives"
            },
            {
              "key": "unionizing_implications",
              "value": "potential increase in costs if a significant portion of employees unionize"
            },
            {
              "key": "nurse_staffing_ratios",
              "value": "operating in states with mandatory nurse staffing ratios affected by regulatory changes"
            },
            {
              "key": "labor_pool_dependence",
              "value": "dependent on labor pool in operating markets for necessary positions"
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_executive_compensation": {
      "value": true,
      "elements": [
        {
          "type": "executive_compensation",
          "page": 16,
          "title": "CMS Payment Adjustments and Reimbursement Updates",
          "data": [
            {
              "key": "National public health emergency declaration",
              "value": "PHE declared in response to COVID-19."
            },
            {
              "key": "CMS policy on quality measures",
              "value": "Pausing or refining several measures across various hospital quality measurement and value-based purchasing programs."
            },
            {
              "key": "2023 HVBP Program adjustments",
              "value": "Hospitals will receive a net neutral payment adjustment equal to the 2% withheld."
            },
            {
              "key": "APC payment rates increase for 2022",
              "value": "Increased by 2.0%."
            },
            {
              "key": "APC payment rates increase for 2023",
              "value": "Estimated increase of 3.8%."
            },
            {
              "key": "Supreme Court ruling impact",
              "value": "Invalidated past payment cuts for hospitals participating in the 340B Drug Pricing Program."
            },
            {
              "key": "340B program reimbursement methodology",
              "value": "Allows hospitals to purchase outpatient drugs at discounted rates."
            },
            {
              "key": "Payment rate change for 340B drugs for 2023",
              "value": "Includes a 3.09% reduction to non-drug services."
            },
            {
              "key": "IRF payment adjustments",
              "value": "Increased by 1.9% for FY 2022 and 3.9% for FY 2023."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "executive_compensation",
          "page": 81,
          "title": "Directors, Executive Officers and Corporate Governance",
          "data": [
            {
              "key": "Executive Compensation Information",
              "value": "Set forth under the headings “Executive Compensation” and “Compensation Committee Interlocks and Insider Participation”."
            },
            {
              "key": "Proxy Materials",
              "value": "To be filed in connection with our 2023 Annual Meeting of Stockholders."
            },
            {
              "key": "SEC Regulation S-K",
              "value": "Item 402(v), relating to pay versus performance."
            },
            {
              "key": "Security Ownership of Certain Beneficial Owners",
              "value": "Information contained under the heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters”."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 82,
          "title": "Equity Compensation Plan Information",
          "data": [
            {
              "key": "plan_type",
              "value": "Equity compensation plans approved by security holders"
            },
            {
              "key": "number_of_securities",
              "value": "9.586"
            },
            {
              "key": "weighted_average",
              "value": "$126.38"
            },
            {
              "key": "securities_available_future",
              "value": "18.262"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Amendment to the Credit Agreement",
          "data": [
            {
              "key": "Amendment Date",
              "value": "March 2, 2009"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA UK Capital Limited, Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 4.8(c) to the Company’s Annual Report on Form 10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2008"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Amendment No. 3 to the Credit Agreement",
          "data": [
            {
              "key": "Amendment Date",
              "value": "June 18, 2009"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA UK Capital Limited, Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 4.1 to the Company’s Current Report on Form 8-K"
            },
            {
              "key": "Filed Date",
              "value": "June 22, 2009"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Extension Amendment No. 1 to the Credit Agreement",
          "data": [
            {
              "key": "Amendment Date",
              "value": "April 6, 2010"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA UK Capital Limited, Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 10.1 to the Company’s Current Report on Form 8-K"
            },
            {
              "key": "Filed Date",
              "value": "April 8, 2010"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Amended and Restated Joinder Agreement No. 1",
          "data": [
            {
              "key": "Amendment Date",
              "value": "November 8, 2010"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q"
            },
            {
              "key": "Quarter Ended",
              "value": "September 30, 2010"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Restatement Agreement",
          "data": [
            {
              "key": "Amendment Date",
              "value": "May 4, 2011"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 10.1 to the Company’s Current Report on Form 8-K"
            },
            {
              "key": "Filed Date",
              "value": "May 9, 2011"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Extension Amendment No. 1",
          "data": [
            {
              "key": "Amendment Date",
              "value": "April 25, 2012"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA UK Capital Limited, Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 10.1 to the Company’s Current Report on Form 8-K"
            },
            {
              "key": "Filed Date",
              "value": "April 26, 2012"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Restatement Agreement",
          "data": [
            {
              "key": "Amendment Date",
              "value": "February 26, 2014"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA UK Capital Limited, Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 4.1 to the Company’s Current Report on Form 8-K"
            },
            {
              "key": "Filed Date",
              "value": "February 28, 2014"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Supplement No. 14",
          "data": [
            {
              "key": "Amendment Date",
              "value": "November 9, 2015"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., Bank of America, N.A. etc."
            },
            {
              "key": "Filed as",
              "value": "Exhibit 4.4(j) to the Company’s Annual Report on Form 10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2018"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 84,
          "title": "Restatement Agreement",
          "data": [
            {
              "key": "Amendment Date",
              "value": "June 28, 2017"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., Bank of America, N.A. etc."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 87,
          "title": "Various Financial Agreements and Indentures",
          "data": [
            {
              "key": "Date of Agreement",
              "value": "November 17, 2006"
            },
            {
              "key": "Involved Parties",
              "value": "Bank of New York Mellon Trust Company, N.A., Bank of America, N.A."
            },
            {
              "key": "Purpose",
              "value": "Trustee and Collateral Agent agreements"
            },
            {
              "key": "Related Documents",
              "value": "Filed as Exhibits to the Company’s Current Reports on Form 8-K and Registration Statement"
            },
            {
              "key": "Other Agreements",
              "value": "Intercreditor Agreements and Registration Rights Agreements"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc.",
          "data": [
            {
              "key": "Document Type",
              "value": "Stock Incentive Plan"
            },
            {
              "key": "Effective Date",
              "value": "Amended and Restated"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.11(b)"
            },
            {
              "key": "Form Type",
              "value": "S-1"
            },
            {
              "key": "File Number",
              "value": "333-171369"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "First Amendment to 2006 Stock Incentive Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "First Amendment"
            },
            {
              "key": "Effective Date",
              "value": "Amended and Restated"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.1"
            },
            {
              "key": "Form Type",
              "value": "10-Q"
            },
            {
              "key": "Quarter Ended",
              "value": "June 30, 2011"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Second Amendment to the 2006 Stock Incentive Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Second Amendment"
            },
            {
              "key": "Effective Date",
              "value": "Amended and Restated"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.1"
            },
            {
              "key": "Form Type",
              "value": "10-Q"
            },
            {
              "key": "Quarter Ended",
              "value": "March 31, 2013"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Management Stockholder’s Agreement",
          "data": [
            {
              "key": "Document Type",
              "value": "Management Stockholder’s Agreement"
            },
            {
              "key": "Effective Date",
              "value": "November 17, 2006"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.12"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2006"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Form of Omnibus Amendment to Management Stockholder’s Agreements",
          "data": [
            {
              "key": "Document Type",
              "value": "Omnibus Amendment"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.39"
            },
            {
              "key": "Form Type",
              "value": "S-1"
            },
            {
              "key": "File Number",
              "value": "333-171369"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Award Agreement"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.1"
            },
            {
              "key": "Form Type",
              "value": "8-K"
            },
            {
              "key": "Filed Date",
              "value": "February 14, 2012"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "2014 Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Award Agreement"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.17(b)"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2013"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Retirement Agreement with Thomas F. Frist, Jr., M.D.",
          "data": [
            {
              "key": "Document Type",
              "value": "Retirement Agreement"
            },
            {
              "key": "Effective Date",
              "value": "January 1, 2002"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.30"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2001"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Amended and Restated HCA Supplemental Executive Retirement Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Supplemental Executive Retirement Plan"
            },
            {
              "key": "Effective Date",
              "value": "December 22, 2010"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.26"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2010"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Amendment to HCA Supplemental Executive Retirement Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Amendment"
            },
            {
              "key": "Effective Date",
              "value": "December 22, 2020"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.7(b)"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2020"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Amended and Restated HCA Restoration Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Restoration Plan"
            },
            {
              "key": "Effective Date",
              "value": "December 22, 2010"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.27"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2010"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Amendment to HCA Restoration Plan",
          "data": [
            {
              "key": "Document Type",
              "value": "Amendment"
            },
            {
              "key": "Effective Date",
              "value": "June 5, 2020"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.5"
            },
            {
              "key": "Form Type",
              "value": "10-Q"
            },
            {
              "key": "Quarter Ended",
              "value": "June 30, 2020"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Employment Agreement with Samuel N. Hazen",
          "data": [
            {
              "key": "Document Type",
              "value": "Employment Agreement"
            },
            {
              "key": "Effective Date",
              "value": "November 16, 2006"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.27(d)"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2006"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Employment Agreement with Charles J. Hall",
          "data": [
            {
              "key": "Document Type",
              "value": "Employment Agreement"
            },
            {
              "key": "Effective Date",
              "value": "November 16, 2006"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.28(d)"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2012"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 92,
          "title": "Amendment to Employment Agreement with Samuel N. Hazen",
          "data": [
            {
              "key": "Document Type",
              "value": "Amendment"
            },
            {
              "key": "Effective Date",
              "value": "February 9, 2011"
            },
            {
              "key": "Filing Reference",
              "value": "Exhibit 10.29(j)"
            },
            {
              "key": "Form Type",
              "value": "10-K"
            },
            {
              "key": "Fiscal Year Ended",
              "value": "December 31, 2010"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 93,
          "title": "Employment Agreement Amendments and Executive Compensation Documents",
          "data": [
            {
              "key": "Amendment 10.9(d)",
              "value": "Second Amendment to Employment Agreement effective January 29, 2015 (Samuel N. Hazen), filed as Exhibit 10.23(i) in 10-K for fiscal year ended December 31, 2014"
            },
            {
              "key": "Amendment 10.9(e)",
              "value": "Third Amendment to Employment Agreement effective January 27, 2016 (Samuel N. Hazen), filed as Exhibit 10.23(j) in 10-K for fiscal year ended December 31, 2015"
            },
            {
              "key": "Amendment 10.9(f)",
              "value": "Amendment to Employment Agreement effective January 27, 2016 (Charles J. Hall), filed as Exhibit 10.23(k) in 10-K for fiscal year ended December 31, 2015"
            },
            {
              "key": "Amendment 10.9(g)",
              "value": "Fourth Amendment to Employment Agreement effective November 14, 2016 (Samuel N. Hazen), filed as Exhibit 10.16(l) in 10-K for fiscal year ended December 31, 2016"
            },
            {
              "key": "Amendment 10.9(h)",
              "value": "Fifth Amendment to Employment Agreement effective January 1, 2019 (Samuel N. Hazen), filed as Exhibit 10.14(i) in 10-K for fiscal year ended December 31, 2018"
            },
            {
              "key": "Signing Bonus Agreement 10.9(i)",
              "value": "Signing Bonus Agreement dated January 24, 2022 between HCA Healthcare, Inc. and Michael R. McAlevey"
            },
            {
              "key": "Other Executive Documents",
              "value": "Includes Indemnification Priority and Information Sharing Agreement (10.10), Assignment and Assumption Agreement (10.11), Omnibus Amendments to Stock and Option Plans (10.12 & 10.13), Stockholders’ Agreement and its Amendment (10.14 & 10.15), Director Restricted Share Unit Agreement (10.16), Executive Severance Policy (10.17), Employee Stock Purchase Plan (10.18), and Stock Appreciation Right Award Agreement (10.19)"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 94,
          "title": "Forms of Stock Appreciation Right Award Agreements Under the 2006 and 2020 Stock Incentive Plans",
          "data": [
            {
              "key": "Form 10.20",
              "value": "2016 Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.21",
              "value": "Director Restricted Share Unit Agreement (Annual Award) Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.22",
              "value": "2017 Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.23",
              "value": "2018 Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.24",
              "value": "2019 Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.25",
              "value": "2019 Performance Share Unit Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.26",
              "value": "2020 Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.27",
              "value": "2020 Performance Share Unit Award Agreement Under the 2006 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.28",
              "value": "2020 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.29",
              "value": "Stock Appreciation Right Award Agreement Under the 2020 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.30",
              "value": "Employee Restricted Share Unit Award Agreement Under the 2020 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.31",
              "value": "Performance Share Unit Award Agreement Under the 2020 Stock Incentive Plan for Key Employees"
            },
            {
              "key": "Form 10.32",
              "value": "2020 Senior Officer Performance Excellence Program"
            },
            {
              "key": "Form 10.33",
              "value": "Director Restricted Share Unit Agreement Under the 2020 Stock Incentive Plan for Key Employees"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 95,
          "title": "Executive Compensation and Award Agreements – HCA Healthcare, Inc.",
          "data": [
            {
              "key": "10.34",
              "value": "Form of 2021 Stock Appreciation Right Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.37 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, and incorporated by reference)."
            },
            {
              "key": "10.35",
              "value": "Form of 2021 Performance Share Unit Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, and incorporated by reference)."
            },
            {
              "key": "10.36",
              "value": "HCA Healthcare, Inc. 2021 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 9, 2021, and incorporated by reference)."
            },
            {
              "key": "10.37",
              "value": "Form of 2022 Stock Appreciation Right Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and incorporated by reference)."
            },
            {
              "key": "10.38",
              "value": "Form of 2022 Performance Share Unit Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.39 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and incorporated by reference)."
            },
            {
              "key": "10.39",
              "value": "HCA Healthcare, Inc. 2022 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 11, 2022, and incorporated by reference)."
            },
            {
              "key": "10.40",
              "value": "Form of 2023 Stock Appreciation Right Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates."
            },
            {
              "key": "10.41",
              "value": "Form of 2023 Performance Share Unit Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates."
            },
            {
              "key": "Additional Documents",
              "value": "Includes subsidiary lists, certification items (e.g., CEO and CFO certifications in items 31.1 and 31.2), and financial statements (items 101 and 104) relevant to overall company reporting."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 111,
          "title": "Share-Based Compensation",
          "data": [
            {
              "key": "Stock Incentive Plans",
              "value": "Our stock incentive plans are designed to promote the long-term financial interests and growth of the Company by attracting and retaining management and other personnel."
            },
            {
              "key": "Employee Stock Purchase Plan",
              "value": "Our employee stock purchase plan provides our participating employees an opportunity to obtain shares of our common stock at a discount."
            },
            {
              "key": "Compensation Expense ESPP 2022",
              "value": "$16 million"
            },
            {
              "key": "Compensation Expense ESPP 2021",
              "value": "$15 million"
            },
            {
              "key": "Compensation Expense ESPP 2020",
              "value": "$13 million"
            },
            {
              "key": "Shares Available for Future Grants",
              "value": "13.826 million"
            },
            {
              "key": "Shares Reserved for ESPP Issuances",
              "value": "4.436 million"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 112,
          "title": "Share-Based Compensation Overview",
          "data": [
            {
              "key": "Risk-free interest rate (2022)",
              "value": "1.64%"
            },
            {
              "key": "Risk-free interest rate (2021)",
              "value": "0.68%"
            },
            {
              "key": "Risk-free interest rate (2020)",
              "value": "1.44%"
            },
            {
              "key": "Expected volatility (2022)",
              "value": "34%"
            },
            {
              "key": "Expected volatility (2021)",
              "value": "36%"
            },
            {
              "key": "Expected volatility (2020)",
              "value": "27%"
            },
            {
              "key": "Expected life, in years (2022)",
              "value": "5.11"
            },
            {
              "key": "Expected life, in years (2021)",
              "value": "6.17"
            },
            {
              "key": "Expected life, in years (2020)",
              "value": "6.15"
            },
            {
              "key": "Expected dividend yield (2022)",
              "value": "0.95%"
            },
            {
              "key": "Expected dividend yield (2021)",
              "value": "1.10%"
            },
            {
              "key": "Expected dividend yield (2020)",
              "value": "1.19%"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 112,
          "title": "Stock Appreciation Rights (SARs) Activity Summary",
          "data": [
            {
              "key": "SARs outstanding, December 31, 2019",
              "value": "11,194"
            },
            {
              "key": "SARs outstanding, December 31, 2020",
              "value": "8,655"
            },
            {
              "key": "SARs outstanding, December 31, 2021",
              "value": "N/A"
            },
            {
              "key": "SARs outstanding, December 31, 2022",
              "value": "6,087"
            },
            {
              "key": "SARs exercisable, December 31, 2022",
              "value": "4,149"
            },
            {
              "key": "Aggregate intrinsic value (in millions)",
              "value": "691"
            },
            {
              "key": "Aggregate intrinsic value (in millions) (2021)",
              "value": "572"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "executive_compensation",
          "page": 128,
          "title": "Certifications of William B. Rutherford",
          "data": [
            {
              "key": "Name",
              "value": "William B. Rutherford"
            },
            {
              "key": "Title",
              "value": "Executive Vice President and Chief Financial Officer"
            },
            {
              "key": "Date",
              "value": "February 17, 2023"
            },
            {
              "key": "Responsibilities",
              "value": "Reviewed annual report; ensured financial statements fairly present the financial condition and results; responsible for disclosure controls and internal control over financial reporting."
            },
            {
              "key": "Certifications",
              "value": "Certifies that report does not contain misleading statements; has evaluated effectiveness of internal controls and disclosed deficiencies."
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_rnd_investment_numbers": {
      "value": false,
      "elements": []
    },
    "has_new_product_launches": {
      "value": false,
      "elements": []
    },
    "has_capital_expenditures": {
      "value": true,
      "elements": [
        {
          "type": "capital_expenditure",
          "page": 4,
          "title": "2022 Capital Investment Overview",
          "data": [
            {
              "key": "Total Capital Investment",
              "value": "$4.4 billion"
            },
            {
              "key": "Details",
              "value": "Investments in existing facilities and outpatient network"
            },
            {
              "key": "Outpatient Investment",
              "value": "Purchase of MD Now Urgent Care - 59 centers in Florida"
            },
            {
              "key": "Significance",
              "value": "Largest urgent care acquisition in the healthcare industry"
            },
            {
              "key": "Impact on Patients",
              "value": "Enhanced access to outpatient care options and statewide network of care"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "capital_expenditure",
          "page": 5,
          "title": "Expansion and Technological Innovation Initiatives",
          "data": [
            {
              "key": "Infrastructure Investment",
              "value": "Plans to build new full-service hospitals in Texas and Florida to meet growing healthcare demands."
            },
            {
              "key": "Technological Innovation",
              "value": "Launched a pilot for the 'Staff Scheduler' system in the Labor and Delivery space using machine learning to optimize staffing, update clinical systems, and improve care delivery."
            },
            {
              "key": "Strategic Partnerships",
              "value": "Formed an oncology research joint venture with McKesson Corporation to expand clinical research and drug development."
            },
            {
              "key": "Awards and Recognition",
              "value": "Received multiple recognitions including Ethisphere's World's Most Ethical Companies, LinkedIn Top Companies ranking, and accolades from Military Times."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_expenditure",
          "page": 11,
          "title": "Growth Agenda and Health Care Facilities Overview",
          "data": [
            {
              "key": "Growth Objectives",
              "value": "Grow presence in existing markets; achieve industry-leading clinical, operational and satisfaction performance; recruit and retain health care professionals; leverage economies of scale; pursue a disciplined development strategy."
            },
            {
              "key": "Investment Focus",
              "value": "Emphasize investments in clinical systems, digital capabilities, innovative care models, workforce development, and enhancement of health care networks and partnerships."
            },
            {
              "key": "Facility Portfolio",
              "value": "Owns and operates a diverse range of health care facilities including 175 general, acute care hospitals with 48,508 licensed beds, 5 psychiatric hospitals, freestanding surgical centers, emergency care facilities, and various outpatient centers."
            },
            {
              "key": "COVID-19 Impact",
              "value": "Acknowledges uncertainty in the duration and extent of COVID-19’s impact on operating results and financial condition due to factors largely beyond control."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_expenditure",
          "page": 75,
          "title": "HCA HEALTHCARE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS – Liquidity and Capital Resources",
          "data": [
            {
              "key": "Cash used in investing activities 2022",
              "value": "$3.389 billion"
            },
            {
              "key": "Cash used in investing activities 2021",
              "value": "$2.643 billion"
            },
            {
              "key": "Cash used in investing activities 2020",
              "value": "$3.393 billion"
            },
            {
              "key": "Excluding acquisitions, capital expenditures 2022",
              "value": "$4.395 billion"
            },
            {
              "key": "Excluding acquisitions, capital expenditures 2021",
              "value": "$3.577 billion"
            },
            {
              "key": "Excluding acquisitions, capital expenditures 2020",
              "value": "$2.835 billion"
            },
            {
              "key": "Planned capital expenditures 2023",
              "value": "$4.3 billion"
            },
            {
              "key": "Estimated additional cost for projects under construction",
              "value": "$4.707 billion"
            },
            {
              "key": "Acquisitions spending 2022 (hospitals and health care entities)",
              "value": "$224 million"
            },
            {
              "key": "Acquisitions spending 2021 (hospitals and health care entities)",
              "value": "$1.105 billion"
            },
            {
              "key": "Acquisitions spending 2020 (hospitals and health care entities)",
              "value": "$568 million"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "capital_expenditure",
          "page": 117,
          "title": "Maturity Schedule and Valuation Analysis",
          "data": [
            {
              "key": "Total Amortized Cost",
              "value": "$415"
            },
            {
              "key": "Total Market Value",
              "value": "$377"
            },
            {
              "key": "Average Expected Maturity",
              "value": "5.3 years"
            },
            {
              "key": "Average Scheduled Maturity",
              "value": "8.6 years"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "capital_expenditure",
          "page": 117,
          "title": "Fair Value Measurements of Assets",
          "data": [
            {
              "key": "Total Investments",
              "value": "$473M"
            },
            {
              "key": "Current Assets",
              "value": "$92M"
            },
            {
              "key": "Net Total",
              "value": "$381M"
            },
            {
              "key": "Level 2 Investments in Debt Securities",
              "value": "$377M"
            },
            {
              "key": "Level 1 Market Funds",
              "value": "$96M"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "capital_expenditure",
          "page": 122,
          "title": "Share Repurchase Transactions",
          "data": [
            {
              "key": "Share Repurchase Authorization",
              "value": "$3 billion in January 2023, $8 billion in January 2022, $6 billion in February 2021, $4 billion in January 2020, and $4 billion in January 2019"
            },
            {
              "key": "Shares Repurchased in 2022",
              "value": "30.747 million shares at average price of $227.67"
            },
            {
              "key": "Shares Repurchased in 2021",
              "value": "37.812 million shares at average price of $217.25"
            },
            {
              "key": "Shares Repurchased in 2020",
              "value": "3.287 million shares at average price of $134.18"
            },
            {
              "key": "Repurchase Authorization Remaining (Dec 31, 2022)",
              "value": "$1.586 billion"
            },
            {
              "key": "Total Benefits Expense",
              "value": "$606 million in 2022, $560 million in 2021, $552 million in 2020"
            },
            {
              "key": "Employee Benefit Plans",
              "value": "Defined contribution plans and nonqualified Restoration Plan"
            },
            {
              "key": "Accrued Benefits Liabilities (Restoration Plan)",
              "value": "$210 million in 2022, $258 million in 2021"
            },
            {
              "key": "SERP Benefits Expense",
              "value": "$22 million for 2022 and 2021, $24 million for 2020"
            },
            {
              "key": "Accrued Benefits Liabilities (SERP)",
              "value": "$137 million in 2022, $201 million in 2021"
            },
            {
              "key": "Defined Benefit Pension Plans Benefits Expense",
              "value": "Credit of $11 million in 2022, expense of $4 million in 2021, expense of $8 million in 2020"
            }
          ],
          "currency": "USD"
        }
      ]
    },
    "has_financial_performance_indicators": {
      "value": true,
      "elements": [
        {
          "type": "financial_performance",
          "page": 1,
          "title": "Анализ данных",
          "data": [
            {
              "key": "Год",
              "value": "2022"
            },
            {
              "key": "Изображение 1",
              "value": "<image_content>"
            },
            {
              "key": "Изображение 2",
              "value": "<image_content>"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 2,
          "title": "2022 by the numbers",
          "data": [
            {
              "key": "People Employed",
              "value": "294K"
            },
            {
              "key": "Payroll and Benefits",
              "value": "$27.7B"
            },
            {
              "key": "Federal, State and Local Taxes Incurred",
              "value": "$5.6B"
            },
            {
              "key": "Capital Investment",
              "value": "$4.4B"
            },
            {
              "key": "Admissions",
              "value": "2.0M+"
            },
            {
              "key": "Patient Encounters",
              "value": "37M+"
            },
            {
              "key": "Emergency Room Visits",
              "value": "9.0M"
            },
            {
              "key": "Uncompensated Care Cost",
              "value": "$3.5B"
            },
            {
              "key": "Enterprise Giving to Community Organizations",
              "value": "$44.2M"
            },
            {
              "key": "Student Loan Assistance",
              "value": "$8.8M"
            },
            {
              "key": "Colleague Giving with HCA Healthcare Matching",
              "value": "$17M"
            },
            {
              "key": "Tuition Reimbursement Benefits",
              "value": "$30.4M"
            },
            {
              "key": "Volunteer Hours",
              "value": "143,878"
            },
            {
              "key": "Charitable Organizations Supported",
              "value": "6,741"
            },
            {
              "key": "Assistance Distributed by HCA Healthcare Hope Fund",
              "value": "$12M"
            },
            {
              "key": "Grants for HCA Healthcare Colleagues and Families",
              "value": "4,427"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 9,
          "title": "Form 10-K Table of Contents",
          "data": [
            {
              "key": "Overview",
              "value": "The provided table appears to be the Table of Contents (INDEX) of a Form 10-K report. It is divided into four parts and lists items related to various topics including Business & Risk Factors, Unresolved Staff Comments, Properties, Legal Proceedings, Market for Registrant's Common Equity, Management’s Discussion and Analysis of Financial Condition and Results of Operations, Disclosure Regarding Foreign Jurisdictions, Corporate Governance, Executive Compensation, Relationships and Related Transactions, Principal Accountant Fees, Exhibits and Financial Statement Schedules, and Form 10-K Summary and Signatures."
            },
            {
              "key": "Page Range",
              "value": "The index items reference pages ranging from 33 to 89, though some sections do not have specified page numbers."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 14,
          "title": "Revenue Distribution by Healthcare Segment (2020-2022)",
          "data": [
            {
              "key": "Medicare revenue 2022",
              "value": "10,447 million"
            },
            {
              "key": "Medicare revenue 2021",
              "value": "10,447 million"
            },
            {
              "key": "Medicare revenue 2020",
              "value": "10,420 million"
            },
            {
              "key": "Managed Medicare revenue 2022",
              "value": "9,201 million"
            },
            {
              "key": "Managed Medicare revenue 2021",
              "value": "8,424 million"
            },
            {
              "key": "Managed Medicare revenue 2020",
              "value": "6,997 million"
            },
            {
              "key": "Medicaid revenue 2022",
              "value": "2,636 million"
            },
            {
              "key": "Medicaid revenue 2021",
              "value": "2,290 million"
            },
            {
              "key": "Medicaid revenue 2020",
              "value": "1,965 million"
            },
            {
              "key": "Managed Medicaid revenue 2022",
              "value": "3,998 million"
            },
            {
              "key": "Managed Medicaid revenue 2021",
              "value": "3,124 million"
            },
            {
              "key": "Managed Medicaid revenue 2020",
              "value": "2,621 million"
            },
            {
              "key": "Managed care and other insurers revenue 2022",
              "value": "29,120 million"
            },
            {
              "key": "Managed care and other insurers revenue 2021",
              "value": "30,295 million"
            },
            {
              "key": "Managed care and other insurers revenue 2020",
              "value": "26,535 million"
            },
            {
              "key": "International revenue 2022",
              "value": "1,317 million"
            },
            {
              "key": "International revenue 2021",
              "value": "1,336 million"
            },
            {
              "key": "International revenue 2020",
              "value": "1,120 million"
            },
            {
              "key": "Unspecified revenue 2022",
              "value": "3,514 million"
            },
            {
              "key": "Unspecified revenue 2021",
              "value": "2,836 million"
            },
            {
              "key": "Unspecified revenue 2020",
              "value": "1,875 million"
            },
            {
              "key": "Total Revenues 2022",
              "value": "60,233 million"
            },
            {
              "key": "Total Revenues 2021",
              "value": "58,752 million"
            },
            {
              "key": "Total Revenues 2020",
              "value": "51,533 million"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 15,
          "title": "CMS MS-DRG Reimbursement, Rate Updates and Related Adjustments",
          "data": [
            {
              "key": "MS-DRG Payment Adjustment Mechanism",
              "value": "Payments are adjusted for area wage differentials. Hospitals receive PPS reimbursement for inpatient capital costs based on MS-DRG weights multiplied by a geographically adjusted federal rate. Outlier payments are provided when treatment costs fall well outside the normal distribution and are financed by offsetting reductions in inpatient PPS rates."
            },
            {
              "key": "Outlier Payment Threshold",
              "value": "A high-cost outlier threshold is set annually targeting estimated outlier payments equaling 5.1% of total inpatient PPS payments."
            },
            {
              "key": "Market Basket Update and Productivity Adjustments FY2022",
              "value": "For fiscal year 2022, CMS increased the MS-DRG rate by approximately 2.5%. This increase reflected a market basket update of 2.7%, reduced by a negative 0.7 percentage point productivity adjustment, and a 0.5 percentage point increase in accordance with MACRA."
            },
            {
              "key": "Market Basket Update and Productivity Adjustments FY2023",
              "value": "For fiscal year 2023, CMS increased the MS-DRG rate by approximately 4.3%, reflecting a market basket update of 4.1%, reduced by a negative 0.3 percentage point productivity adjustment, and increased by 0.5 percentage points as required by MACRA."
            },
            {
              "key": "Impact on Operations",
              "value": "A decrease in payment rates or an increase below the rise in costs may adversely affect hospitals’ results of operations."
            },
            {
              "key": "Additional CMS Programs and Adjustments",
              "value": "Includes policies such as the two-midnight rule, post-acute care transfer reductions, Hospital Inpatient Quality Reporting Program penalties, EHR usage penalties, HAC adjustments, readmission reductions under HRRP, and a 2.0% reduction under the Hospital Value-Based Purchasing (HVBP) Program whose collected amount is redistributed as incentive payments tied to quality performance."
            },
            {
              "key": "Quality Performance Domains under HVBP",
              "value": "Hospitals are scored on clinical outcomes, efficiency and cost reduction, safety, and person and community engagement."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 18,
          "title": "CMS Home Health and Hospice Payment Rates Update",
          "data": [
            {
              "key": "CMS Home Health Payment Rate Increase FY2022",
              "value": "3.2%"
            },
            {
              "key": "Home Health Payment Update Percentage FY2022",
              "value": "2.6%"
            },
            {
              "key": "Market Basket Increase (Home Health 2022)",
              "value": "3.1%"
            },
            {
              "key": "Productivity Adjustment (Home Health 2022)",
              "value": "-0.5 percentage point"
            },
            {
              "key": "CMS Home Health Payment Rate Increase FY2023",
              "value": "0.7%"
            },
            {
              "key": "Home Health Payment Update Percentage FY2023",
              "value": "4.0%"
            },
            {
              "key": "Market Basket Increase (Home Health 2023)",
              "value": "4.1%"
            },
            {
              "key": "Productivity Adjustment (Home Health 2023)",
              "value": "-0.1 percentage point"
            },
            {
              "key": "Hospice Payment Rate Increase FY2022",
              "value": "2.0%"
            },
            {
              "key": "Market Basket Update (Hospice FY2022)",
              "value": "2.7%"
            },
            {
              "key": "Productivity Adjustment (Hospice FY2022)",
              "value": "-0.7 percentage point"
            },
            {
              "key": "Hospice Payment Rate Increase FY2023",
              "value": "3.8%"
            },
            {
              "key": "Market Basket Update (Hospice FY2023)",
              "value": "4.1%"
            },
            {
              "key": "Productivity Adjustment (Hospice FY2023)",
              "value": "-0.3 percentage point"
            },
            {
              "key": "Quality Data Reporting Penalty (Home Health)",
              "value": "2.0 percentage point reduction if required quality data not submitted; increases to 4.0 percentage points for hospices from 2024"
            },
            {
              "key": "HHVBP Model Impact",
              "value": "Performance-based adjustments up to ±5%; first performance year in 2023 affecting payments in 2025"
            },
            {
              "key": "Review Choice Demonstration",
              "value": "Applies in selected states (e.g., NC, FL, TX) with options including pre-claim, post-payment, or minimal post-payment review with 25% reduction"
            },
            {
              "key": "NOA Requirement",
              "value": "One-time Notice of Admission required, with penalties if not submitted within 5 calendar days"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 19,
          "title": "Physician Services Reimbursement and Fee Schedule Updates",
          "data": [
            {
              "key": "Reimbursement System",
              "value": "Physician Fee Schedule system under CMS"
            },
            {
              "key": "RVU Calculation",
              "value": "Based on work (time and intensity), practice expense, and malpractice insurance expense, each adjusted geographically"
            },
            {
              "key": "Budget Neutrality Requirement",
              "value": "RVU changes must be nearly budget neutral; total payments cannot differ by more than $20 million from baseline"
            },
            {
              "key": "Conversion Factor Change for 2023",
              "value": "Reduced by approximately 4.48% with a partial congressional offset of 2.5%, resulting in an approximate 2% payment reduction"
            },
            {
              "key": "Quality Payment Program (QPP)",
              "value": "Medicare payments are adjusted based on provider participation in QPP, with two tracks available: Advanced APM and MIPS"
            },
            {
              "key": "Incentive Payments",
              "value": "Advanced APM track offered a 5.0% incentive for 2022 (paid in 2024) and a potential 3.5% for 2023 (paid in 2025); MIPS adjustments up to 9% in 2025"
            },
            {
              "key": "Wage Index Adjustments",
              "value": "Payment rates are adjusted for local wage differences using a wage index, with a new permanent cap to smooth variations"
            },
            {
              "key": "Other CMS Payment Structures",
              "value": "Includes fee schedules for therapies, durable medical equipment, laboratory services, and adjustments via MAC contracts and bids"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 20,
          "title": "Overview of Medicare and Medicaid Programs",
          "data": [
            {
              "key": "Medicare Program Goals",
              "value": "Conduct post-payment reviews to detect and correct improper payments in the fee-for-service Medicare program."
            },
            {
              "key": "RAC Compensation Model",
              "value": "Compensation for RACs is based on their review of claims submitted to Medicare for billing compliance and the amount of overpayments and underpayments identified."
            },
            {
              "key": "RAC Audit Limitations",
              "value": "CMS limits the number of claims that RACs may audit based on each provider’s claim denial rate."
            },
            {
              "key": "RAC Program Implementation",
              "value": "CMS has implemented the RAC program on a permanent, nationwide basis."
            },
            {
              "key": "Appeal Process",
              "value": "Payment recoveries resulting from reviews and denials are appealable through administrative and judicial processes."
            },
            {
              "key": "Medicaid Funding",
              "value": "Medicaid programs are funded jointly by the federal government and the states."
            },
            {
              "key": "COVID-19 Impact on Medicaid",
              "value": "Medicaid enrollment has increased as a result of COVID-19 relief legislation."
            },
            {
              "key": "Medicaid Expansion",
              "value": "States may opt out of the Medicaid expansion without losing existing federal Medicaid funding."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 24,
          "title": "Hospital Utilization Metrics",
          "data": [
            {
              "key": "Number of hospitals at end of period",
              "value": "182, 182, 185"
            },
            {
              "key": "Number of freestanding outpatient surgery centers at end of period",
              "value": "126, 125, 121"
            },
            {
              "key": "Number of licensed beds at end of period",
              "value": "49,281, 48,803, 49,265"
            },
            {
              "key": "Weighted average beds in service",
              "value": "41,982, 42,148, 42,246"
            },
            {
              "key": "Admissions",
              "value": "2,075,459, 2,089,975, 2,009,909"
            },
            {
              "key": "Equivalent admissions",
              "value": "3,611,299, 3,536,238, 3,312,330"
            },
            {
              "key": "Average length of stay (days)",
              "value": "5.1, 5.2, 5.1"
            },
            {
              "key": "Average daily census",
              "value": "28,778, 29,752, 27,734"
            },
            {
              "key": "Occupancy rate",
              "value": "2%, TA%, 69%"
            },
            {
              "key": "Emergency room visits",
              "value": "8,971,951, 8,475,345, 7,450,307"
            },
            {
              "key": "Outpatient surgeries",
              "value": "1,023,239, 1,008,236, 882,483"
            },
            {
              "key": "Inpatient surgeries",
              "value": "522,151, 522,069, 522,385"
            },
            {
              "key": "Days revenues in accounts receivable",
              "value": "53, 49, 45"
            },
            {
              "key": "Outpatient revenues as a % of patient revenues",
              "value": "38%, 37%, 35%"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 62,
          "title": "Stock Performance Comparison: HCA Healthcare vs Market Indices",
          "data": [
            {
              "key": "date",
              "value": "2017-12-31"
            },
            {
              "key": "HCA",
              "value": "100"
            },
            {
              "key": "SP500",
              "value": "100"
            },
            {
              "key": "SP_Healthcare",
              "value": "100"
            },
            {
              "key": "date",
              "value": "2018-12-31"
            },
            {
              "key": "HCA",
              "value": "140"
            },
            {
              "key": "SP500",
              "value": "95"
            },
            {
              "key": "SP_Healthcare",
              "value": "105"
            },
            {
              "key": "date",
              "value": "2019-12-31"
            },
            {
              "key": "HCA",
              "value": "170"
            },
            {
              "key": "SP500",
              "value": "125"
            },
            {
              "key": "SP_Healthcare",
              "value": "125"
            },
            {
              "key": "date",
              "value": "2020-12-31"
            },
            {
              "key": "HCA",
              "value": "190"
            },
            {
              "key": "SP500",
              "value": "145"
            },
            {
              "key": "SP_Healthcare",
              "value": "145"
            },
            {
              "key": "date",
              "value": "2021-12-31"
            },
            {
              "key": "HCA",
              "value": "300"
            },
            {
              "key": "SP500",
              "value": "190"
            },
            {
              "key": "SP_Healthcare",
              "value": "180"
            },
            {
              "key": "date",
              "value": "2022-12-31"
            },
            {
              "key": "HCA",
              "value": "285"
            },
            {
              "key": "SP500",
              "value": "155"
            },
            {
              "key": "SP_Healthcare",
              "value": "175"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 64,
          "title": "HCA Healthcare, Inc. MD&A – Financial Performance and Risk Factors",
          "data": [
            {
              "key": "Company",
              "value": "HCA HEALTHCARE, INC."
            },
            {
              "key": "Forward-Looking Statements Risk Factors",
              "value": "Includes risks such as tax audits, litigation, cybersecurity incidents, EHR technology use, natural disasters, changes in tax laws, and other risk factors."
            },
            {
              "key": "Net Income 2022",
              "value": "$5.643 billion"
            },
            {
              "key": "Diluted EPS 2022",
              "value": "$19.15"
            },
            {
              "key": "Net Income 2021",
              "value": "$6.956 billion"
            },
            {
              "key": "Diluted EPS 2021",
              "value": "$21.16"
            },
            {
              "key": "Gains on Facility Sales 2022",
              "value": "$1.301 billion"
            },
            {
              "key": "Losses on Debt Retirement 2022",
              "value": "$78 million"
            },
            {
              "key": "Gains on Facility Sales 2021",
              "value": "$1.620 billion"
            },
            {
              "key": "Losses on Debt Retirement 2021",
              "value": "$12 million"
            },
            {
              "key": "Tax Benefits from Equity Award Settlements 2022",
              "value": "$77 million"
            },
            {
              "key": "Tax Benefits from Equity Award Settlements 2021",
              "value": "$119 million"
            },
            {
              "key": "Shares Used for Diluted EPS 2022",
              "value": "294.666 million"
            },
            {
              "key": "Shares Used for Diluted EPS 2021",
              "value": "328.752 million"
            },
            {
              "key": "Common Stock Repurchased 2022",
              "value": "30.747 million shares"
            },
            {
              "key": "Common Stock Repurchased 2021",
              "value": "37.812 million shares"
            },
            {
              "key": "Revenues 2022",
              "value": "$60.233 billion"
            },
            {
              "key": "Revenues 2021",
              "value": "$58.752 billion"
            },
            {
              "key": "Operating Cash Flows 2022",
              "value": "$8.522 billion"
            },
            {
              "key": "Operating Cash Flows 2021",
              "value": "$8.959 billion"
            },
            {
              "key": "Interest Expense 2022",
              "value": "$1.741 billion"
            },
            {
              "key": "Interest Expense 2021",
              "value": "$1.566 billion"
            },
            {
              "key": "Volume Metrics",
              "value": "Consolidated and same facility admissions, inpatient and outpatient surgical volumes, and emergency room visits showed mixed changes, with a slight decline in consolidated admissions and increases in same facility admissions and emergency room visits."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 66,
          "title": "HCA HealthCare, Inc. Management's Discussion and Analysis of Financial Condition and Results of Operations",
          "data": [
            {
              "key": "Revenues Recording",
              "value": "Revenues are recorded during the period health care services are provided, based upon estimated amounts due from payers."
            },
            {
              "key": "Contractual Allowances Estimates",
              "value": "Estimates of contractual allowances under managed care health plans are based upon payment terms specified in contractual agreements."
            },
            {
              "key": "Medicare and Medicaid Programs",
              "value": "Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation."
            },
            {
              "key": "Charity Care Eligibility Criteria",
              "value": "Patients treated at hospitals for non-elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care."
            },
            {
              "key": "Patient Discounts Eligibility",
              "value": "Patients treated at hospitals for non-elective care, who have income above 400% of the federal poverty level, are eligible for certain other discounts."
            },
            {
              "key": "Implicit Price Concessions",
              "value": "Estimated implicit price concessions are recorded for all uninsured accounts, regardless of the age of those accounts."
            },
            {
              "key": "Reasonable Collection Efforts",
              "value": "Accounts are written off when all reasonable collection efforts have been performed."
            },
            {
              "key": "Hindsight Analysis",
              "value": "Management relies on results of detailed reviews of historical writeoffs and collections."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 67,
          "title": "HCA HEALTHCARE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)",
          "data": [
            {
              "key": "Patient care costs (2022)",
              "value": "51180"
            },
            {
              "key": "Patient care costs (2021)",
              "value": "49074"
            },
            {
              "key": "Patient care costs (Prior Period)",
              "value": "44271"
            },
            {
              "key": "Cost-to-charges ratio (2022)",
              "value": "11.0%"
            },
            {
              "key": "Cost-to-charges ratio (2021)",
              "value": "11.3%"
            },
            {
              "key": "Cost-to-charges ratio (Prior Period)",
              "value": "12.0%"
            },
            {
              "key": "Total uncompensated care (2022)",
              "value": "31734"
            },
            {
              "key": "Total uncompensated care (2021)",
              "value": "29642"
            },
            {
              "key": "Total uncompensated care (Prior Period)",
              "value": "29029"
            },
            {
              "key": "Estimated cost of total uncompensated care (2022)",
              "value": "3491"
            },
            {
              "key": "Estimated cost of total uncompensated care (2021)",
              "value": "3350"
            },
            {
              "key": "Estimated cost of total uncompensated care (Prior Period)",
              "value": "3483"
            },
            {
              "key": "Provisions for professional liability risks (2022)",
              "value": "517"
            },
            {
              "key": "Provisions for professional liability risks (2021)",
              "value": "453"
            },
            {
              "key": "Provisions for professional liability risks (2020)",
              "value": "435"
            },
            {
              "key": "Reductions to professional liability risks (2022)",
              "value": "55"
            },
            {
              "key": "Reductions to professional liability risks (2021)",
              "value": "87"
            },
            {
              "key": "Reductions to professional liability risks (2020)",
              "value": "112"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 68,
          "title": "Professional Liability Claims Reserves Movement",
          "data": [
            {
              "key": "year",
              "value": "2022"
            },
            {
              "key": "reserves_start",
              "value": "1967"
            },
            {
              "key": "provision_current_year",
              "value": "538"
            },
            {
              "key": "provision_prior_years",
              "value": "-21"
            },
            {
              "key": "total_provision",
              "value": "517"
            },
            {
              "key": "payments_current_year",
              "value": "4"
            },
            {
              "key": "payments_prior_years",
              "value": "493"
            },
            {
              "key": "total_payments",
              "value": "497"
            },
            {
              "key": "effect_reinsurance",
              "value": "-4"
            },
            {
              "key": "reserves_end",
              "value": "1983"
            },
            {
              "key": "year",
              "value": "2021"
            },
            {
              "key": "reserves_start",
              "value": "1924"
            },
            {
              "key": "provision_current_year",
              "value": "530"
            },
            {
              "key": "provision_prior_years",
              "value": "-77"
            },
            {
              "key": "total_provision",
              "value": "453"
            },
            {
              "key": "payments_current_year",
              "value": "5"
            },
            {
              "key": "payments_prior_years",
              "value": "379"
            },
            {
              "key": "total_payments",
              "value": "384"
            },
            {
              "key": "effect_reinsurance",
              "value": "-26"
            },
            {
              "key": "reserves_end",
              "value": "1967"
            },
            {
              "key": "year",
              "value": "2020"
            },
            {
              "key": "reserves_start",
              "value": "1781"
            },
            {
              "key": "provision_current_year",
              "value": "519"
            },
            {
              "key": "provision_prior_years",
              "value": "-84"
            },
            {
              "key": "total_provision",
              "value": "435"
            },
            {
              "key": "payments_current_year",
              "value": "5"
            },
            {
              "key": "payments_prior_years",
              "value": "287"
            },
            {
              "key": "total_payments",
              "value": "292"
            },
            {
              "key": "effect_reinsurance",
              "value": "null"
            },
            {
              "key": "reserves_end",
              "value": "1924"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 69,
          "title": "Income Taxes and Revenue/Volume Trends",
          "data": [
            {
              "key": "Revenue 2022",
              "value": "$60.233 billion"
            },
            {
              "key": "Revenue 2021",
              "value": "$58.752 billion"
            },
            {
              "key": "Revenue 2020",
              "value": "$51.533 billion"
            },
            {
              "key": "Increase in Revenue 2022",
              "value": "2.5%"
            },
            {
              "key": "Increase in Revenue 2021",
              "value": "14.0%"
            },
            {
              "key": "Same facility revenue growth 2022",
              "value": "3.2%"
            },
            {
              "key": "Same facility revenue growth 2021",
              "value": "14.4%"
            },
            {
              "key": "Consolidated admissions change 2022",
              "value": "-0.7%"
            },
            {
              "key": "Consolidated admissions change 2021",
              "value": "4.0%"
            },
            {
              "key": "Consolidated surgeries change 2022",
              "value": "1.0%"
            },
            {
              "key": "Consolidated surgeries change 2021",
              "value": "8.9%"
            },
            {
              "key": "Consolidated emergency room visits change 2022",
              "value": "5.9%"
            },
            {
              "key": "Consolidated emergency room visits change 2021",
              "value": "13.8%"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 70,
          "title": "Healthcare Coverage Distribution (2020-2022)",
          "data": [
            {
              "key": "Aedicare",
              "value": "22%"
            },
            {
              "key": "Managed Medicare",
              "value": "23"
            },
            {
              "key": "Aedicaid",
              "value": "4"
            },
            {
              "key": "Janaged Medicaid",
              "value": "14"
            },
            {
              "key": "Aanaged care and insurers",
              "value": "30"
            },
            {
              "key": "Jninsured",
              "value": "7"
            },
            {
              "key": "Total",
              "value": "100%"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 70,
          "title": "Healthcare Programs and Insurance Distribution (2020-2022)",
          "data": [
            {
              "key": "fedicare",
              "value": "23%"
            },
            {
              "key": "Aanaged Medicare",
              "value": "17"
            },
            {
              "key": "fedicaid",
              "value": "7"
            },
            {
              "key": "Aanaged Medicaid",
              "value": "8"
            },
            {
              "key": "Aanaged care and insurers",
              "value": "45"
            },
            {
              "key": "Total",
              "value": "100%"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 71,
          "title": "HCA Healthcare, Inc. Financial Statement",
          "data": [
            {
              "key": "Revenues",
              "value": "60233 million (2022), 58752 million (2021), 51533 million (2020)"
            },
            {
              "key": "Salaries and benefits",
              "value": "27685 million (46.0% in 2022), 26779 million (45.6% in 2021), 23874 million (46.3% in 2020)"
            },
            {
              "key": "Supplies",
              "value": "9371 million (2022), 9481 million (2021), 8369 million (2020)"
            },
            {
              "key": "Other operating expenses",
              "value": "11155 million (18.5% in 2022), 9961 million (17.0% in 2021), 9307 million (18.1% in 2020)"
            },
            {
              "key": "Net income attributable to HCA Healthcare, Inc.",
              "value": "5643 million (9.4% in 2022), 6956 million (11.8% in 2021), 3754 million (7.3% in 2020)"
            },
            {
              "key": "Summary",
              "value": "The table outlines operating performance over three years, highlighting a 2.5% year-over-year revenue growth in the most recent period and emphasizing that salaries and benefits constitute the largest expense (approximately 46% of revenue)."
            },
            {
              "key": "Additional Metrics",
              "value": "Key performance indicators such as revenue per equivalent admission are provided as supplemental operational insights."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 72,
          "title": "HCA Healthcare, Inc. Management's Discussion and Analysis of Financial Condition and Results of Operations",
          "data": [
            {
              "key": "Number of hospitals at end of period",
              "value": "182"
            },
            {
              "key": "Number of freestanding outpatient surgical centers at end of period",
              "value": "126"
            },
            {
              "key": "Number of licensed beds at end of period",
              "value": "49,281"
            },
            {
              "key": "Weighted average beds in service",
              "value": "41,982"
            },
            {
              "key": "Admissions",
              "value": "2,075,459"
            },
            {
              "key": "Equivalent admissions",
              "value": "3,611,299"
            },
            {
              "key": "Average length of stay (days)",
              "value": "5.1"
            },
            {
              "key": "Average daily census",
              "value": "28,778"
            },
            {
              "key": "Occupancy",
              "value": "72%"
            },
            {
              "key": "Emergency room visits",
              "value": "8,971,951"
            },
            {
              "key": "Outpatient surgeries",
              "value": "1,023,239"
            },
            {
              "key": "Inpatient surgeries",
              "value": "522,151"
            },
            {
              "key": "Days revenues in accounts receivable",
              "value": "53"
            },
            {
              "key": "Outpatient revenues as a % of patient revenues",
              "value": "38%"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 73,
          "title": "Management's Discussion and Analysis of Financial Condition and Results of Operations",
          "data": [
            {
              "key": "Net income 2022",
              "value": "$5.643 billion, or $19.15 per diluted share"
            },
            {
              "key": "Net income 2021",
              "value": "$6.956 billion, or $21.16 per diluted share"
            },
            {
              "key": "Gains on sales of facilities 2022",
              "value": "$1.301 billion, or $2.46 per diluted share"
            },
            {
              "key": "Losses on retirement of debt 2022",
              "value": "$78 million, or $0.20 per diluted share"
            },
            {
              "key": "Impact of Hurricane Ian",
              "value": "Approximately $85 million"
            },
            {
              "key": "Tax benefits 2022",
              "value": "$77 million, or $0.26 per diluted share"
            },
            {
              "key": "Tax benefits 2021",
              "value": "$119 million, or $0.36 per diluted share"
            },
            {
              "key": "Shares used for diluted earnings per share 2022",
              "value": "294.666 million shares"
            },
            {
              "key": "Shares used for diluted earnings per share 2021",
              "value": "328.752 million shares"
            },
            {
              "key": "Share repurchase 2022",
              "value": "30.747 million shares"
            },
            {
              "key": "Share repurchase 2021",
              "value": "37.812 million shares"
            },
            {
              "key": "Consolidated admissions decline 2022",
              "value": "0.7%"
            },
            {
              "key": "Same facility admissions increase 2022",
              "value": "0.5%"
            },
            {
              "key": "Consolidated revenues 2022",
              "value": "$60.233 billion"
            },
            {
              "key": "Consolidated revenues 2021",
              "value": "$58.752 billion"
            },
            {
              "key": "Salaries and benefits % of revenues 2022",
              "value": "46.0%"
            },
            {
              "key": "Salaries and benefits % of revenues 2021",
              "value": "45.6%"
            },
            {
              "key": "Share-based compensation expense 2022",
              "value": "$341 million"
            },
            {
              "key": "Share-based compensation expense 2021",
              "value": "$440 million"
            },
            {
              "key": "Provisions for losses related to professional liability 2022",
              "value": "$517 million"
            },
            {
              "key": "Provisions for losses related to professional liability 2021",
              "value": "$453 million"
            },
            {
              "key": "Equity in earnings of affiliates 2022",
              "value": "$45 million"
            },
            {
              "key": "Equity in earnings of affiliates 2021",
              "value": "$113 million"
            },
            {
              "key": "Decline in equity earnings",
              "value": "$68 million due to sale of equity investment in 2021"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 74,
          "title": "Management's Discussion and Analysis of Financial Condition and Results of Operations",
          "data": [
            {
              "key": "Depreciation and amortization percentage",
              "value": "5.0% in 2022, 4.9% in 2021"
            },
            {
              "key": "Depreciation expense",
              "value": "$2.941 billion in 2022, $2.826 billion in 2021"
            },
            {
              "key": "Interest expense",
              "value": "$1.741 billion in 2022, $1.566 billion in 2021"
            },
            {
              "key": "Debt balance",
              "value": "$37.363 billion in 2022, $32.109 billion in 2021"
            },
            {
              "key": "Effective interest rate",
              "value": "4.7% in 2022, 4.9% in 2021"
            },
            {
              "key": "Gains on sales of facilities",
              "value": "$1.301 billion in 2022, $1.620 billion in 2021"
            },
            {
              "key": "Senior notes issued",
              "value": "$6.000 billion in 2022, $2.350 billion in 2021"
            },
            {
              "key": "Liquidity and capital source",
              "value": "Cash flows from operating activities, issuances of debt, equity securities, sales of hospitals"
            },
            {
              "key": "Cash provided by operating activities",
              "value": "$8.522 billion in 2022, $8.959 billion in 2021"
            },
            {
              "key": "Working capital",
              "value": "$3.741 billion at December 31, 2022, $3.960 billion at December 31, 2021"
            },
            {
              "key": "Effective income tax rates",
              "value": "23.6% in 2022, 23.3% in 2021"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 76,
          "title": "Financial Condition and Results of Operations",
          "data": [
            {
              "key": "Debt Total",
              "value": "$38.084 billion (2022), $34.579 billion (2021)"
            },
            {
              "key": "Interest Expense",
              "value": "$1.741 billion (2022), $1.566 billion (2021)"
            },
            {
              "key": "New Senior Notes Issued",
              "value": "$6.000 billion"
            },
            {
              "key": "Use of Proceeds",
              "value": "Pay down revolving credit facilities and redeem senior notes"
            },
            {
              "key": "Insurance Investment Securities",
              "value": "$473 million (2022)"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 78,
          "title": "Internal Controls and Disclosure Controls Evaluation",
          "data": [
            {
              "key": "Financial Statements Reference",
              "value": "Consolidated financial statements referenced on Page F-1 of the annual report on Form 10-K"
            },
            {
              "key": "Item 9 - Changes and Disagreements with Accountants",
              "value": "None"
            },
            {
              "key": "Disclosure Controls and Procedures",
              "value": "Evaluated under management supervision with participation of principal executive and financial officers; concluded effective as of report end period"
            },
            {
              "key": "Internal Control Over Financial Reporting",
              "value": "Assessed using the 2013 Integrated Framework; management concluded effectiveness as of December 31, 2022"
            },
            {
              "key": "External Audit",
              "value": "Ernst & Young LLP issued a report on internal control over financial reporting"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 79,
          "title": "Attestation Report of the Independent Registered Public Accounting Firm",
          "data": [
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Date of Opinion",
              "value": "February 17, 2023"
            },
            {
              "key": "Audit Opinion",
              "value": "Unqualified opinion on internal control over financial reporting as of December 31, 2022."
            },
            {
              "key": "Period Covered",
              "value": "Consolidated balance sheets and related statements for the years ended December 31, 2022, 2021, and additional notes."
            },
            {
              "key": "Report Date",
              "value": "February 17, 2023"
            },
            {
              "key": "PCAOB Standards",
              "value": "Conducted in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB)."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 97,
          "title": "Report of Independent Registered Public Accounting Firm",
          "data": [
            {
              "key": "description",
              "value": "rt of Independent Registered Public Accounting Firm olidated Financial Statements:"
            },
            {
              "key": "description",
              "value": "Consolidated Income Statements for the years ended December 31, 2022, 2021 and 2020.0... Consolidated Comprehensive Income Statements for the years ended December 31, 2022"
            },
            {
              "key": "description",
              "value": "Consolidated Balance Sheets, December 31, 2022 and 2021.. Consolidated Statements of Stockholders' Equity (Deficit) for the years ended December"
            },
            {
              "key": "description",
              "value": "and 2020 Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and Notes to Consolidated Financial Statements"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 98,
          "title": "Audit Report and Opinion on Financial Statements",
          "data": [
            {
              "key": "Report Title",
              "value": "Report of Independent Registered Public Accounting Firm"
            },
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Financial Statements Scope",
              "value": "Consolidated balance sheets, income statements, comprehensive income, stockholders’ equity (deficit) and cash flows for the years ended December 31, 2022 and 2021"
            },
            {
              "key": "Reporting Period",
              "value": "As of December 31, 2022 and December 31, 2021; three-year period ended December 31, 2022"
            },
            {
              "key": "Audit Opinion",
              "value": "Unqualified opinion – the consolidated financial statements present fairly, in all material respects, the financial position, operations, and cash flows"
            },
            {
              "key": "Auditing Standards",
              "value": "PCAOB standards; Internal Control-Integrated Framework (2013)"
            },
            {
              "key": "Internal Control Audit",
              "value": "Audited as of December 31, 2022 with an unqualified opinion issued on February 17, 2023"
            },
            {
              "key": "Critical Audit Matters",
              "value": "Matters related to material accounts and disclosures involving especially challenging, subjective, or complex judgments, as communicated to the audit committee"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 99,
          "title": "Revenue Recognition",
          "data": [
            {
              "key": "Revenues (2022)",
              "value": "$60.233 billion"
            },
            {
              "key": "Estimation of Contractual Allowances",
              "value": "Based on payment terms specified in contractual agreements."
            },
            {
              "key": "Management Review Process",
              "value": "Management continually reviews the estimation process to consider updates to laws and regulations."
            },
            {
              "key": "Primary Collection Risks",
              "value": "Related to uninsured patient accounts."
            },
            {
              "key": "Professional Liability Risks Reserves (2022)",
              "value": "$2.043 billion"
            },
            {
              "key": "Provision for Losses (2022)",
              "value": "$517 million"
            },
            {
              "key": "Estimation Methodology",
              "value": "Utilizes individual case-basis valuations and actuarial analyses."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 101,
          "title": "HCA Healthcare, Inc. Financial Statement",
          "data": [
            {
              "key": "REVENUES",
              "value": "60233"
            },
            {
              "key": "Salaries and benefits",
              "value": "27685"
            },
            {
              "key": "Supplies",
              "value": "9371"
            },
            {
              "key": "Other operating expenses",
              "value": "11155"
            },
            {
              "key": "Income before income taxes",
              "value": "8580"
            },
            {
              "key": "Provision for income taxes",
              "value": "1746"
            },
            {
              "key": "Net income attributable to HCA Healthcare, Inc.",
              "value": "5643"
            },
            {
              "key": "Basic earnings per share",
              "value": "19.43"
            },
            {
              "key": "Diluted earnings per share",
              "value": "19.15"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 102,
          "title": "HCA Healthcare, Inc. Consolidated Comprehensive Income Statements for the Years Ended December 31, 2022, 2021 and 2020",
          "data": [
            {
              "key": "Net income (2022)",
              "value": "6,834"
            },
            {
              "key": "Net income (2021)",
              "value": "7,721"
            },
            {
              "key": "Net income (2020)",
              "value": "4,387"
            },
            {
              "key": "Foreign currency translation (2022)",
              "value": "(111)"
            },
            {
              "key": "Foreign currency translation (2021)",
              "value": "(9)"
            },
            {
              "key": "Foreign currency translation (2020)",
              "value": "18"
            },
            {
              "key": "Unrealized gains (losses) on available-for-sale securities (2022)",
              "value": "(55)"
            },
            {
              "key": "Unrealized gains (losses) on available-for-sale securities (2021)",
              "value": "(16)"
            },
            {
              "key": "Unrealized gains (losses) on available-for-sale securities (2020)",
              "value": "14"
            },
            {
              "key": "Defined benefit plans (2022)",
              "value": "(54)"
            },
            {
              "key": "Defined benefit plans (2021)",
              "value": "(16)"
            },
            {
              "key": "Defined benefit plans (2020)",
              "value": "14"
            },
            {
              "key": "Change in fair value of derivative financial instruments (2022)",
              "value": "6"
            },
            {
              "key": "Change in fair value of derivative financial instruments (2021)",
              "value": "1"
            },
            {
              "key": "Change in fair value of derivative financial instruments (2020)",
              "value": "0"
            },
            {
              "key": "Change Interest costs (2022)",
              "value": "2"
            },
            {
              "key": "Change Interest costs (2021)",
              "value": "37"
            },
            {
              "key": "Change Interest costs (2020)",
              "value": "(66)"
            },
            {
              "key": "Other comprehensive income (loss) before taxes (2022)",
              "value": "(99)"
            },
            {
              "key": "Other comprehensive income (loss) before taxes (2021)",
              "value": "128"
            },
            {
              "key": "Other comprehensive income (loss) before taxes (2020)",
              "value": "(53)"
            },
            {
              "key": "Income taxes related to comprehensive income (2022)",
              "value": "(13)"
            },
            {
              "key": "Income taxes related to comprehensive income (2021)",
              "value": "30"
            },
            {
              "key": "Income taxes related to comprehensive income (2020)",
              "value": "(11)"
            },
            {
              "key": "Other comprehensive income (loss) (2022)",
              "value": "(86)"
            },
            {
              "key": "Other comprehensive income (loss) (2021)",
              "value": "98"
            },
            {
              "key": "Other comprehensive income (loss) (2020)",
              "value": "(42)"
            },
            {
              "key": "Comprehensive income (2022)",
              "value": "6,748"
            },
            {
              "key": "Comprehensive income (2021)",
              "value": "7,819"
            },
            {
              "key": "Comprehensive income (2020)",
              "value": "4,345"
            },
            {
              "key": "Comprehensive income attributable to noncontrolling interests (2022)",
              "value": "1,191"
            },
            {
              "key": "Comprehensive income attributable to noncontrolling interests (2021)",
              "value": "765"
            },
            {
              "key": "Comprehensive income attributable to noncontrolling interests (2020)",
              "value": "633"
            },
            {
              "key": "Comprehensive income attributable to HCA Healthcare, Inc. (2022)",
              "value": "5,557"
            },
            {
              "key": "Comprehensive income attributable to HCA Healthcare, Inc. (2021)",
              "value": "7,054"
            },
            {
              "key": "Comprehensive income attributable to HCA Healthcare, Inc. (2020)",
              "value": "3,712"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 103,
          "title": "HCA Healthcare, Inc. Balance Sheet Extract",
          "data": [
            {
              "key": "Total Assets",
              "value": "$52,438M"
            },
            {
              "key": "Total Liabilities",
              "value": "$50,742M"
            },
            {
              "key": "Cash and Cash Equivalents",
              "value": "$908M"
            },
            {
              "key": "Accounts Receivable",
              "value": "$8,891M"
            },
            {
              "key": "Inventories & Other",
              "value": "$13,643M (2022), $13,542M (2021)"
            },
            {
              "key": "Property and Equipment",
              "value": "$25,575M (Net) in 2022"
            },
            {
              "key": "Goodwill and Intangibles",
              "value": "$9,653M (2022), $9,540M (2021)"
            },
            {
              "key": "Accumulated Depreciation",
              "value": "$29,182M (2022), $27,287M (2021)"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 105,
          "title": "Cash Flow Statement",
          "data": [
            {
              "key": "Net Income",
              "value": "Net income decreased from $7,721M to $6,834M in the most recent year."
            },
            {
              "key": "Operating Activities",
              "value": "Operating cash flow remained strong but slightly decreased to $8,522M."
            },
            {
              "key": "Investing Activities",
              "value": "Significant stock repurchases of $7,000M in the most recent period."
            },
            {
              "key": "Financing Activities",
              "value": "Cash position declined to $908M from $1,451M."
            },
            {
              "key": "Summary",
              "value": "This table represents a cash flow statement showing operating, investing, and financing activities across three years."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 106,
          "title": "HCA HEALTHCARE, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - NOTE 1 — ACCOUNTING POLICIES",
          "data": [
            {
              "key": "Reporting Entity",
              "value": "HCA Healthcare, Inc. is a holding company with affiliates owning and operating hospitals, freestanding surgery centers, and endoscopy centers across 20 states and England."
            },
            {
              "key": "Basis of Presentation",
              "value": "Financial statements prepared in conformity with GAAP, requiring estimates and assumptions; includes all subsidiaries and entities controlled by HCA."
            },
            {
              "key": "COVID-19 Impact",
              "value": "The impact of COVID-19 on operations is uncertain, driven by multiple factors beyond control, and its long-term effect cannot be precisely estimated."
            },
            {
              "key": "Revenues",
              "value": "Revenues relate to patient contracts for healthcare services, recognized as performance obligations are satisfied; inpatient services average around five days, while outpatient services are recognized in less than one day."
            },
            {
              "key": "Expense Details",
              "value": "General and administrative expenses include corporate office costs of $378M in 2022, $400M in 2021, and $416M in 2020."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "financial_performance",
          "page": 107,
          "title": "Revenue Distribution by Healthcare Segment (2020-2022)",
          "data": [
            {
              "key": "Medicare",
              "value": "$10,447 million (17.3%) in 2022"
            },
            {
              "key": "Managed Medicare",
              "value": "$9,201 million (15.3%) in 2022"
            },
            {
              "key": "Medicaid",
              "value": "$2,636 million (4.4%) in 2022"
            },
            {
              "key": "Managed Medicaid",
              "value": "$3,998 million (6.6%) in 2022"
            },
            {
              "key": "Managed care and other insurers",
              "value": "$29,120 million (48.3%) in 2022"
            },
            {
              "key": "International",
              "value": "$1,317 million (2.2%) in 2022"
            },
            {
              "key": "Other",
              "value": "$3,514 million (5.9%) in 2022"
            },
            {
              "key": "Total Revenues",
              "value": "$60,233 million (100.0%) in 2022"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 108,
          "title": "HCA Healthcare, Inc. Notes to Consolidated Financial Statements",
          "data": [
            {
              "key": "Estimated implicit price concessions for 2022",
              "value": "$6.780 billion"
            },
            {
              "key": "Estimated implicit price concessions for 2021",
              "value": "$6.784 billion"
            },
            {
              "key": "Patient care costs (2022)",
              "value": "$51,180"
            },
            {
              "key": "Patient care costs (2021)",
              "value": "$49,074"
            },
            {
              "key": "Patient care costs (2020)",
              "value": "$44,271"
            },
            {
              "key": "Cost-to-charges ratio (2022)",
              "value": "11.0%"
            },
            {
              "key": "Cost-to-charges ratio (2021)",
              "value": "11.3%"
            },
            {
              "key": "Cost-to-charges ratio (2020)",
              "value": "12.0%"
            },
            {
              "key": "Total uncompensated care (2022)",
              "value": "-$31,734"
            },
            {
              "key": "Total uncompensated care (2021)",
              "value": "$29,642"
            },
            {
              "key": "Total uncompensated care (2020)",
              "value": "$29,029"
            },
            {
              "key": "Estimated cost of total uncompensated care (2022)",
              "value": "$3,491"
            },
            {
              "key": "Estimated cost of total uncompensated care (2021)",
              "value": "$3,350"
            },
            {
              "key": "Estimated cost of total uncompensated care (2020)",
              "value": "$3,483"
            },
            {
              "key": "Charity care (2022)",
              "value": "$13.615 billion"
            },
            {
              "key": "Charity care (2021)",
              "value": "$13.644 billion"
            },
            {
              "key": "Charity care (2020)",
              "value": "$13.763 billion"
            },
            {
              "key": "Estimated cost of charity care (2022)",
              "value": "$1.498 billion"
            },
            {
              "key": "Estimated cost of charity care (2021)",
              "value": "$1.542 billion"
            },
            {
              "key": "Estimated cost of charity care (2020)",
              "value": "$1.652 billion"
            },
            {
              "key": "Outstanding checks (2022)",
              "value": "$656 million"
            },
            {
              "key": "Outstanding checks (2021)",
              "value": "$536 million"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 109,
          "title": "HCA HEALTHCARE, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – ACCOUNTING POLICIES (continued)",
          "data": [
            {
              "key": "Accounts Receivable",
              "value": "Payment sources from federal and state agencies (Medicare and Medicaid), managed care plans, commercial insurers, employers, and patients. Days revenues in accounts receivable were 53 days (2022), 49 days (2021) and 45 days (2020)."
            },
            {
              "key": "Inventories",
              "value": "Stated at the lower of cost (first-in, first-out) or market."
            },
            {
              "key": "Depreciation Expense",
              "value": "$2.941 billion in 2022, $2.826 billion in 2021, and $2.693 billion in 2020 computed using the straight-line method."
            },
            {
              "key": "Property and Equipment",
              "value": "Buildings depreciated over 10-40 years; equipment over 4-10 years. Impairment assessments based on future cash flow projections and fair value estimates."
            },
            {
              "key": "Investments of Insurance Subsidiaries",
              "value": "Investment securities classified as 'available-for-sale' and recorded at fair value. Quarterly assessments are performed to evaluate credit-related or noncredit-related declines in fair value."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 110,
          "title": "Accounting Policies and Goodwill Impairment Testing",
          "data": [
            {
              "key": "Goodwill Impairment Testing",
              "value": "Subject to annual impairment tests, performed at reporting unit level. No impairments recognized for 2022, 2021, or 2020."
            },
            {
              "key": "Goodwill Increase 2022",
              "value": "$262 million from acquisitions."
            },
            {
              "key": "Goodwill Decline 2022",
              "value": "$105 million due to foreign currency translation."
            },
            {
              "key": "Goodwill Increase 2021",
              "value": "$1.002 billion from acquisitions."
            },
            {
              "key": "Goodwill Decline 2021",
              "value": "$75 million due to foreign currency translation."
            },
            {
              "key": "Intangible Assets Decline 2022",
              "value": "$44 million due to amortization."
            },
            {
              "key": "Intangible Assets Increase 2021",
              "value": "$60 million from acquisitions."
            },
            {
              "key": "Market Capitalization Cost 2022",
              "value": "Included in interest expense, $29 million for debt issuance amortization."
            },
            {
              "key": "Professional Liability Claims Reserves 2022",
              "value": "$2.043 billion."
            },
            {
              "key": "Provisions for Losses 2022",
              "value": "$517 million."
            },
            {
              "key": "Adjustments for Professional Liability Risks 2022",
              "value": "$55 million reduction."
            },
            {
              "key": "Net Payments for Claims 2022",
              "value": "$497 million."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 120,
          "title": "Lease Assets and Liabilities Summary",
          "data": [
            {
              "key": "Right-of-use operating lease assets",
              "value": "2,065"
            },
            {
              "key": "Property and equipment",
              "value": "587"
            },
            {
              "key": "Total lease liabilities",
              "value": "2,826"
            },
            {
              "key": "Operating leases weighted-average remaining term",
              "value": "10.1 years"
            },
            {
              "key": "Total lease assets (2022)",
              "value": "2,652"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 120,
          "title": "Finance Lease Expense Breakdown",
          "data": [
            {
              "key": "Depreciation and amortization (2022)",
              "value": "163"
            },
            {
              "key": "Interest (2022)",
              "value": "29"
            },
            {
              "key": "Total (2022)",
              "value": "1,168"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 120,
          "title": "Cash paid for amounts included in the measurement of lease liabilities",
          "data": [
            {
              "key": "Operating cash flows for operating leases (2022)",
              "value": "473"
            },
            {
              "key": "Operating cash flows for finance leases (2022)",
              "value": "29"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 123,
          "title": "NOTE 13 — SEGMENT AND GEOGRAPHIC INFORMATION / Revenue and Financial Metrics by Business Segment (2020-2022)",
          "data": [
            {
              "key": "National Group Revenue 2022",
              "value": "30350"
            },
            {
              "key": "American Group Revenue 2022",
              "value": "26865"
            },
            {
              "key": "Corporate and other Revenue 2022",
              "value": "3018"
            },
            {
              "key": "Total Revenue 2022",
              "value": "60233"
            },
            {
              "key": "Adjusted EBITDA - National Group 2022",
              "value": "6379"
            },
            {
              "key": "Adjusted EBITDA - American Group 2022",
              "value": "6055"
            },
            {
              "key": "Adjusted EBITDA - Corporate 2022",
              "value": "-367"
            },
            {
              "key": "Total Adjusted EBITDA 2022",
              "value": "12067"
            },
            {
              "key": "Depreciation - National Group 2022",
              "value": "1464"
            },
            {
              "key": "Depreciation - American Group 2022",
              "value": "1219"
            },
            {
              "key": "Depreciation - Corporate 2022",
              "value": "286"
            },
            {
              "key": "Total Depreciation 2022",
              "value": "2969"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 123,
          "title": "Financial Performance Metrics (2020-2022)",
          "data": [
            {
              "key": "Adjusted segment EBITDA 2022",
              "value": "12067"
            },
            {
              "key": "Depreciation and amortization 2022",
              "value": "2969"
            },
            {
              "key": "Interest expense 2022",
              "value": "1741"
            },
            {
              "key": "Gains/Losses on retirement of debt 2022",
              "value": "-1223"
            },
            {
              "key": "Income before income taxes 2022",
              "value": "8580"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 124,
          "title": "Goodwill and Other Intangible Assets by Business Segment",
          "data": [
            {
              "key": "2020",
              "value": "National Group: 1775, American Group: 5775, Corporate and Other: 1028, Total: 8578"
            },
            {
              "key": "2021",
              "value": "National Group: 2492, American Group: 5832, Corporate and Other: 1216, Total: 9540"
            },
            {
              "key": "2022",
              "value": "National Group: 2652, American Group: 5861, Corporate and Other: 1140, Total: 9653"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 125,
          "title": "Changes in Accumulated Other Comprehensive Income Components",
          "data": [
            {
              "key": "2019 - Available for Sale",
              "value": "14"
            },
            {
              "key": "2019 - Foreign Currency",
              "value": "-283"
            },
            {
              "key": "2019 - Defined Benefit",
              "value": "-187"
            },
            {
              "key": "2019 - Derivative Instruments",
              "value": "-4"
            },
            {
              "key": "2019 - Total",
              "value": "-460"
            },
            {
              "key": "2020 - Available for Sale",
              "value": "25"
            },
            {
              "key": "2020 - Foreign Currency",
              "value": "-271"
            },
            {
              "key": "2020 - Defined Benefit",
              "value": "-220"
            },
            {
              "key": "2020 - Derivative Instruments",
              "value": "-36"
            },
            {
              "key": "2020 - Total",
              "value": "-502"
            },
            {
              "key": "2021 - Available for Sale",
              "value": "12"
            },
            {
              "key": "2021 - Foreign Currency",
              "value": "-278"
            },
            {
              "key": "2021 - Defined Benefit",
              "value": "-132"
            },
            {
              "key": "2021 - Derivative Instruments",
              "value": "-6"
            },
            {
              "key": "2021 - Total",
              "value": "-404"
            },
            {
              "key": "2022 - Available for Sale",
              "value": "-30"
            },
            {
              "key": "2022 - Foreign Currency",
              "value": "-373"
            },
            {
              "key": "2022 - Defined Benefit",
              "value": "-87"
            },
            {
              "key": "2022 - Derivative Instruments",
              "value": "0"
            },
            {
              "key": "2022 - Total",
              "value": "-490"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 126,
          "title": "Accrued Expenses Summary",
          "data": [
            {
              "key": "Defined contribution benefit plans",
              "value": "$612 million"
            },
            {
              "key": "Right-of-use operating leases",
              "value": "$364 million"
            },
            {
              "key": "Taxes other than income",
              "value": "$371 million"
            },
            {
              "key": "Interest",
              "value": "$402 million"
            },
            {
              "key": "Government stimulus refund liability",
              "value": "$81 million"
            },
            {
              "key": "Other",
              "value": "$1,236 million"
            },
            {
              "key": "Total",
              "value": "$3,581 million"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "financial_performance",
          "page": 127,
          "title": "EXHIBIT 31.1 CERTIFICATIONS",
          "data": [
            {
              "key": "Certifier",
              "value": "Samuel N. Hazen"
            },
            {
              "key": "Position",
              "value": "Chief Executive Officer"
            },
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Report Type",
              "value": "Annual report on Form 10-K"
            },
            {
              "key": "Certification Details",
              "value": "Certifies that the report contains no materially untrue statements or omissions, that the financial statements fairly present the financial condition, results of operations, and cash flows, and that internal controls and disclosure procedures have been adequately designed, implemented and evaluated."
            },
            {
              "key": "Certification Date",
              "value": "February 17, 2023"
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_dividend_policy_changes": {
      "value": true,
      "elements": [
        {
          "type": "dividend_policy",
          "page": 59,
          "title": "Dividend Payments and Investor Influence",
          "data": [
            {
              "key": "Dividend Program Initiation Year",
              "value": "2018"
            },
            {
              "key": "Quarterly Dividend Declared in 2022",
              "value": "$0.56 per share"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "dividend_policy",
          "page": 132,
          "title": "HCA Healthcare Dividend and Corporate Information",
          "data": [
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Report Type",
              "value": "Form 10-K for the year ended December 31, 2022"
            },
            {
              "key": "Transfer Agent",
              "value": "Corporate Information Transfer Agent and Registrar EQ Shareowner Services, P.O. Box 64874, St. Paul, Minnesota 55164-0874; Certified/Overnight Mail: EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, Minnesota 55120"
            },
            {
              "key": "Auditor",
              "value": "Ernst & Young LLP, Nashville, Tennessee"
            },
            {
              "key": "Corporate Headquarters",
              "value": "One Park Plaza, Nashville, Tennessee 37203; Phone: 615-344-9551"
            },
            {
              "key": "Stock Listing",
              "value": "NYSE under the symbol 'HCA'"
            },
            {
              "key": "Shareholder Count",
              "value": "Approximately 400 shareholders of record as of February 24, 2023"
            },
            {
              "key": "Dividend Declaration Date",
              "value": "January 26, 2023"
            },
            {
              "key": "Dividend Amount",
              "value": "$0.60 per share"
            },
            {
              "key": "Dividend Payment Date",
              "value": "March 31, 2023"
            },
            {
              "key": "Record Date",
              "value": "March 17, 2023"
            },
            {
              "key": "Annual Meeting",
              "value": "April 19, 2023 at 2:00 pm local time via virtual webcast (www.virtualshareholdermeeting.com/HCA2023)"
            },
            {
              "key": "Investor Relations Contact",
              "value": "Investor Relations, HCA Healthcare, Inc., One Park Plaza, Nashville, TN 37203 or via www.HCAhealthcare.com"
            }
          ],
          "currency": "USD"
        }
      ]
    },
    "has_share_buyback_plans": {
      "value": true,
      "elements": [
        {
          "type": "share_buyback",
          "page": 61,
          "title": "Share Repurchase Activity - Fourth Quarter 2022 and Dividend Declarations",
          "data": [
            {
              "key": "Share Repurchase Authorizations",
              "value": "February 2021: $6 billion, January 2022: $8 billion, January 2023: $3 billion"
            },
            {
              "key": "Q4 2022 Share Repurchase Table Title",
              "value": "Share Repurchase Activity - Fourth Quarter 2022"
            },
            {
              "key": "Q4 2022 Share Repurchase Summary",
              "value": "The table details repurchase activity from October to December 2022 with increasing price per share from $205.58 to $239.71 and a reduction in remaining repurchase authorization from $2.745B to $1.586B."
            },
            {
              "key": "Total Fourth Quarter 2022 Repurchase",
              "value": "6,781,181 shares at an average price of $224.09 per share"
            },
            {
              "key": "Dividend Declarations",
              "value": "During 2022, four quarterly dividends of $0.56 per share were declared (totaling $2.24 per share) and on January 26, 2023, a quarterly dividend of $0.60 per share was declared payable on March 31, 2023."
            },
            {
              "key": "Common Stock Trading",
              "value": "Traded on NYSE under the symbol 'HCA'"
            },
            {
              "key": "Record Holders as of Feb 1, 2023",
              "value": "Approximately 400 holders of record"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "share_buyback",
          "page": 104,
          "title": "Statement of Changes in Stockholders' Equity",
          "data": [
            {
              "key": "Company",
              "value": "HCA HEALTHCARE, INC."
            },
            {
              "key": "Document Title",
              "value": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)"
            },
            {
              "key": "Period Covered",
              "value": "Years ended December 31, 2020, 2021, and 2022 (with historical data from 2019)"
            },
            {
              "key": "Significant Share Buyback",
              "value": "Repurchase of common stock of -30.747 million shares with a reported impact of -$7,000 million in 2021"
            },
            {
              "key": "Dividend Declarations",
              "value": "Cash dividends declared noted ($0.43 and $1.92 per share)"
            },
            {
              "key": "Other Transactions",
              "value": "Includes share-based benefit plans, distributions to noncontrolling interests, and changes in retained earnings"
            },
            {
              "key": "Currency",
              "value": "USD"
            }
          ],
          "currency": "USD"
        }
      ]
    },
    "has_capital_structure_changes": {
      "value": true,
      "elements": [
        {
          "type": "capital_structure",
          "page": 60,
          "title": "Hospital and Bed Distribution by State & Properties Overview",
          "data": [
            {
              "key": "Table Title",
              "value": "Hospital and Bed Distribution by State"
            },
            {
              "key": "Table Summary",
              "value": "This table presents a distribution of hospitals and beds across different US states and international locations. Texas and Florida have the highest numbers, with a total of 182 hospitals and 49,281 beds."
            },
            {
              "key": "Additional Facilities",
              "value": "In addition to the hospitals, the company operates 126 freestanding surgery centers, 21 freestanding endoscopy centers, and medical office buildings primarily occupied by physicians practicing at the hospitals."
            },
            {
              "key": "Mortgaged Properties",
              "value": "Twelve general, acute care hospitals and five other properties have been mortgaged to support obligations under the senior secured cash flow credit facility."
            },
            {
              "key": "Headquarters & Regional Service Centers",
              "value": "Headquarters occupies approximately 2,031,000 square feet in the Nashville, Tennessee area, with additional regional service centers in markets where hospitals operate."
            },
            {
              "key": "Legal Proceedings Reference",
              "value": "Item 3 refers to Note 10 – Contingencies in the consolidated financial statements."
            },
            {
              "key": "Mine Safety Disclosures",
              "value": "None."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 85,
          "title": "Credit, Security, and Joinder Agreements Reference",
          "data": [
            {
              "key": "Joinder Agreement No. 8",
              "value": "Dated July 16, 2019; HCA Inc. as borrower, guarantors, Bank of America, N.A. as administrative and collateral agent; filed as Exhibit 4.1 to the 8-K filed July 22, 2019."
            },
            {
              "key": "Joinder Agreement No. 9",
              "value": "Dated October 8, 2019; HCA Inc. as borrower, guarantors, Bank of America, N.A. as administrative and collateral agent; filed as Exhibit 4.1 to the 8-K filed October 10, 2019."
            },
            {
              "key": "Joinder Agreement No. 10",
              "value": "Dated November 20, 2019; HCA Inc. as borrower, guarantors, Bank of America, N.A. as administrative and collateral agent; filed as Exhibit 4.1 to the 8-K filed November 21, 2019."
            },
            {
              "key": "Restatement Agreement (June 30, 2021)",
              "value": "Restatement Agreement to the Credit Agreement dated November 17, 2006; filed as Exhibit 4.10 to the 8-K filed July 1, 2021."
            },
            {
              "key": "Restatement Agreement (January 4, 2023)",
              "value": "Restatement Agreement among HCA Inc., guarantors, and Bank of America, N.A.; filed as Exhibit 4.1 to the 8-K filed January 4, 2023."
            },
            {
              "key": "Security Agreement",
              "value": "Dated November 17, 2006 and amended/restated as of March 2, 2009; involving the Company, subsidiary grantors, and Bank of America, N.A. as Collateral Agent; filed as Exhibit 4.10 to the 10-K for fiscal year ended December 31, 2008."
            },
            {
              "key": "Supplement No. 2 to Security Agreement",
              "value": "Dated October 27, 2011; supplement to the Amended and Restated Security Agreement; filed as Exhibit 4.5(b) to the 10-K for fiscal year ended December 31, 2018."
            },
            {
              "key": "Schedule of Omitted Supplements to the Security Agreement",
              "value": "Dated November 17, 2006 and amended/restated as of March 2, 2009; filed pursuant to Instruction 2 to Item 601 of Regulation S-K."
            },
            {
              "key": "Pledge Agreement",
              "value": "Dated November 17, 2006 and amended/restated as of March 2, 2009; involving the Company, subsidiary pledgors, and Bank of America, N.A. as Collateral Agent; filed as Exhibit 4.11 to the 10-K for fiscal year ended December 31, 2008."
            },
            {
              "key": "Supplement No. 1 to Pledge Agreement",
              "value": "Dated October 27, 2011; supplement to the Amended and Restated Pledge Agreement; filed as Exhibit 4.6(b) to the 10-K for fiscal year ended December 31, 2018."
            },
            {
              "key": "Schedule of Omitted Supplements to the Pledge Agreement",
              "value": "Dated November 6, 2006 and amended/restated as of March 2, 2009; filed pursuant to Instruction 2 to Item 601 of Regulation S-K."
            },
            {
              "key": "$2,500,000,000 Credit Agreement",
              "value": "Dated September 30, 2011; involving HCA Inc., subsidiary borrowers, lenders, and Bank of America, N.A. as administrative agent; filed as Exhibit 4.4 to the 8-K filed October 3, 2011."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 88,
          "title": "Debt Securities – Indentures and Debenture Forms",
          "data": [
            {
              "key": "4.14(e)",
              "value": "Fourth Supplemental Indenture, dated November 14, 2006, by and between the Company and The Bank of New York, as Trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed November 16, 2006, and incorporated herein by reference)."
            },
            {
              "key": "4.15",
              "value": "Form of 7.5% Debenture due 2023 (filed as Exhibit 4.17 to the Company’s Registration Statement on Form S-4, File No. 333-145054, and incorporated herein by reference)."
            },
            {
              "key": "4.16",
              "value": "Form of 8.36% Debenture due 2024 (filed as Exhibit 4.18 to the Company’s Registration Statement on Form S-4, File No. 333-145054, and incorporated herein by reference)."
            },
            {
              "key": "4.17",
              "value": "Form of Fixed Rate Global Medium-Term Note (filed as Exhibit 4.19 to the Company’s Registration Statement on Form S-4, File No. 333-145054, and incorporated herein by reference)."
            },
            {
              "key": "4.18",
              "value": "Form of Floating Rate Global Medium-Term Note (filed as Exhibit 4.20 to the Company’s Registration Statement on Form S-4, File No. 333-145054, and incorporated herein by reference)."
            },
            {
              "key": "4.19",
              "value": "Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004, and incorporated herein by reference)."
            },
            {
              "key": "4.20",
              "value": "Form of 7.50% Debenture due 2095 (filed as Exhibit 4.23 to the Company’s Registration Statement on Form S-4, File No. 333-145054, and incorporated herein by reference)."
            },
            {
              "key": "4.21",
              "value": "Form of 7.05% Debenture due 2027 (filed as Exhibit 4.24 to the Company’s Registration Statement on Form S-4, File No. 333-145054, and incorporated herein by reference)."
            },
            {
              "key": "4.22",
              "value": "7.50% Note due 2033 in the principal amount of $250,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed November 6, 2003, and incorporated herein by reference)."
            },
            {
              "key": "4.23",
              "value": "Form of Indenture of HCA Inc. (filed as Exhibit 4.2 to the Registrant’s Registration Statement on Form S-3, File No. 333-175791, and incorporated herein by reference)."
            },
            {
              "key": "4.24",
              "value": "Indenture dated August 1, 2011, by and among HCA Inc., the guarantors named on Schedule I thereto, Delaware Trust Company (as successor to Law Debenture Trust Company of New York) as trustee, and Deutsche Bank Trust Company Americas as paying agent, registrar and transfer agent (filed as Exhibit 4.5 to the Company’s Registration Statement on Form S-3, File No. 333-226709, and incorporated herein by reference)."
            },
            {
              "key": "4.25",
              "value": "Indenture dated December 6, 2012, by and among HCA Holdings, Inc., Law Debenture Trust Company of New York as trustee, and Deutsche Bank Trust Company Americas as registrar, paying agent and transfer agent (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed December 6, 2012, and incorporated herein by reference)."
            },
            {
              "key": "4.26",
              "value": "Supplemental Indenture No. 8, dated March 17, 2014, by and among HCA Inc., HCA Holdings, Inc., the subsidiary guarantors named therein, Law Debenture Trust Company of New York as trustee, and Deutsche Bank Trust Company Americas as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed March 21, 2014, and incorporated herein by reference) – including the Form of 5.00% Senior Secured Notes due 2024."
            },
            {
              "key": "4.28",
              "value": "Additional Receivables Intercreditor Agreement, dated March 17, 2014, by and between Bank of America, N.A. as ABL Collateral Agent and Bank of America, N.A. as New First Lien Collateral Agent (filed as Exhibit 4.9 to the Company’s Current Report on Form 8-K filed March 21, 2014, and incorporated herein by reference)."
            },
            {
              "key": "4.29",
              "value": "Supplemental Indenture No. 10, dated October 17, 2014, by and among HCA Inc., HCA Holdings, Inc., the subsidiary guarantors named therein, Law Debenture Trust Company of New York as trustee, and Deutsche Bank Trust Company Americas as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed October 17, 2014, and incorporated herein by reference)."
            },
            {
              "key": "4.30",
              "value": "Form of 5.25% Senior Secured Notes due 2025 (included in Exhibit 4.29)."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "capital_structure",
          "page": 89,
          "title": "Supplemental Indentures and Notes",
          "data": [
            {
              "key": "Indenture Number",
              "value": "4.9"
            },
            {
              "key": "Filing Date",
              "value": "October 17, 2014"
            },
            {
              "key": "Notes Details",
              "value": "5.375% Senior Notes due 2025"
            },
            {
              "key": "Indenture Number",
              "value": "4.32"
            },
            {
              "key": "Filing Date",
              "value": "January 16, 2015"
            },
            {
              "key": "Notes Details",
              "value": "5.875% Senior Notes due 2026"
            },
            {
              "key": "Indenture Number",
              "value": "4.34"
            },
            {
              "key": "Filing Date",
              "value": "May 20, 2015"
            },
            {
              "key": "Indenture Number",
              "value": "4.35"
            },
            {
              "key": "Filing Date",
              "value": "November 13, 2015"
            },
            {
              "key": "Notes Details",
              "value": "5.250% Senior Secured Notes due 2026"
            },
            {
              "key": "Indenture Number",
              "value": "4.37"
            },
            {
              "key": "Filing Date",
              "value": "December 8, 2015"
            },
            {
              "key": "Indenture Number",
              "value": "4.38"
            },
            {
              "key": "Filing Date",
              "value": "March 15, 2016"
            },
            {
              "key": "Indenture Number",
              "value": "4.40"
            },
            {
              "key": "Filing Date",
              "value": "March 15, 2016"
            },
            {
              "key": "Indenture Number",
              "value": "4.41"
            },
            {
              "key": "Filing Date",
              "value": "August 15, 2016"
            },
            {
              "key": "Indenture Number",
              "value": "4.43"
            },
            {
              "key": "Filing Date",
              "value": "August 15, 2016"
            },
            {
              "key": "Indenture Number",
              "value": "4.44"
            },
            {
              "key": "Filing Date",
              "value": "December 9, 2016"
            },
            {
              "key": "Indenture Number",
              "value": "4.45"
            },
            {
              "key": "Filing Date",
              "value": "June 22, 2017"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 90,
          "title": "Exhibit Listings of Debt Instruments and Indentures",
          "data": [
            {
              "key": "Form of 5.500% Senior Secured Notes due 2047",
              "value": "Included in Exhibit 4.45"
            },
            {
              "key": "Additional Receivables Intercreditor Agreement (June 22, 2017)",
              "value": "By and between Bank of America, N.A. as ABL Collateral Agent and Bank of America, N.A. as First Lien Collateral Agent; filed as Exhibit 4.7 in the 8-K dated June 22, 2017"
            },
            {
              "key": "Supplemental Indenture No. 19 (August 23, 2018)",
              "value": "By and among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company (as trustee) and Deutsche Bank Trust Company Americas (as paying agent, registrar and transfer agent); filed as Exhibit 4.2 in the 8-K dated August 23, 2018"
            },
            {
              "key": "Form of 5.375% Senior Notes Due 2026",
              "value": "Included in Exhibit 4.48"
            },
            {
              "key": "Supplemental Indenture No. 20 (August 23, 2018)",
              "value": "By and among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company (as trustee) and Deutsche Bank Trust Company Americas (as paying agent, registrar and transfer agent); filed as Exhibit 4.3 in the 8-K dated August 23, 2018"
            },
            {
              "key": "Form of 5.625% Senior Notes Due 2028",
              "value": "Included in Exhibit 4.50"
            },
            {
              "key": "Supplemental Indenture No. 21 (January 22, 2019)",
              "value": "By and among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company (as trustee) and Deutsche Bank Trust Company Americas (as paying agent, registrar and transfer agent); filed as Exhibit 4.4 in the 8-K dated January 22, 2019"
            },
            {
              "key": "Supplemental Indenture No. 22 (January 30, 2019)",
              "value": "By and among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company (as trustee) and Deutsche Bank Trust Company Americas (as paying agent, registrar and transfer agent); filed as Exhibit 4.2 in the 8-K dated January 30, 2019"
            },
            {
              "key": "Form of 5.875% Senior Notes Due 2029",
              "value": "Included in Exhibit 4.53"
            },
            {
              "key": "Supplemental Indenture No. 23 (June 12, 2019)",
              "value": "By and among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors, Delaware Trust Company (as trustee) and Deutsche Bank Trust Company Americas (as paying agent, registrar and transfer agent); filed as Exhibit 4.2 in the 8-K dated June 12, 2019"
            },
            {
              "key": "Supplemental Indenture No. 24 (June 12, 2019)",
              "value": "Filed as Exhibit 4.3 in the 8-K dated June 12, 2019"
            },
            {
              "key": "Supplemental Indenture No. 25 (June 12, 2019)",
              "value": "Filed as Exhibit 4.4 in the 8-K dated June 12, 2019"
            },
            {
              "key": "Form of 4 1/8% Senior Secured Notes due 2029",
              "value": "Included in Exhibit 4.55"
            },
            {
              "key": "Form of 5 1/8% Senior Secured Notes due 2039",
              "value": "Included in Exhibit 4.56"
            },
            {
              "key": "Form of 5 1/4% Senior Secured Notes due 2049",
              "value": "Included in Exhibit 4.57"
            },
            {
              "key": "Additional Receivables Intercreditor Agreement (June 12, 2019)",
              "value": "By and between Bank of America, N.A. as ABL Collateral Agent and Bank of America, N.A. as First Lien Collateral Agent; filed as Exhibit 4.11 in the 8-K dated June 12, 2019"
            },
            {
              "key": "Supplemental Indenture No. 26 (February 26, 2020)",
              "value": "By and among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company (as trustee) and Deutsche Bank Trust Company Americas (as paying agent, registrar and transfer agent); filed as Exhibit 4.2 in the 8-K dated February 26, 2020"
            },
            {
              "key": "Form of 3.500% Senior Notes Due 2030",
              "value": "Included in Exhibit 4.62"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Supplemental Indenture No. 27",
          "data": [
            {
              "key": "Date",
              "value": "June 30, 2021"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, Deutsche Bank Trust Company Americas"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.2 to the Company’s Current Report on Form 8-K filed July 1, 2021"
            },
            {
              "key": "Type",
              "value": "Supplemental Indenture"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Supplemental Indenture No. 28",
          "data": [
            {
              "key": "Date",
              "value": "June 30, 2021"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, Deutsche Bank Trust Company Americas"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.3 to the Company’s Current Report on Form 8-K filed July 1, 2021"
            },
            {
              "key": "Type",
              "value": "Supplemental Indenture"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Additional Receivables Intercreditor Agreement",
          "data": [
            {
              "key": "Date",
              "value": "June 30, 2021"
            },
            {
              "key": "Parties",
              "value": "Bank of America, N.A"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.9 to the Company’s Current Report on Form 8-K filed July 1, 2021"
            },
            {
              "key": "Type",
              "value": "Intercreditor Agreement"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Supplemental Indenture No. 29",
          "data": [
            {
              "key": "Date",
              "value": "March 9, 2022"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, Deutsche Bank Trust Company Americas"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.2 to the Company’s Current Report on Form 8-K filed March 10, 2022"
            },
            {
              "key": "Type",
              "value": "Supplemental Indenture"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Supplemental Indenture No. 30",
          "data": [
            {
              "key": "Date",
              "value": "March 9, 2022"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, Deutsche Bank Trust Company Americas"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.3 to the Company’s Current Report on Form 8-K filed March 10, 2022"
            },
            {
              "key": "Type",
              "value": "Supplemental Indenture"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Supplemental Indenture No. 31",
          "data": [
            {
              "key": "Date",
              "value": "March 9, 2022"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, Deutsche Bank Trust Company Americas"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.4 to the Company’s Current Report on Form 8-K filed March 10, 2022"
            },
            {
              "key": "Type",
              "value": "Supplemental Indenture"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 91,
          "title": "Registration Rights Agreement",
          "data": [
            {
              "key": "Date",
              "value": "March 9, 2022"
            },
            {
              "key": "Parties",
              "value": "HCA Inc., HCA Healthcare, Inc., Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC"
            },
            {
              "key": "Executed As",
              "value": "Exhibit 4.16 to the Company’s Current Report on Form 8-K filed March 10, 2022"
            },
            {
              "key": "Type",
              "value": "Registration Rights Agreement"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "capital_structure",
          "page": 118,
          "title": "HCA HEALTHCARE, INC. - Note 7 & Note 8 Financial Statement Details",
          "data": [
            {
              "key": "Table Title 1",
              "value": "Assets: Investments of insurance subsidiaries - Fair Value Measurements"
            },
            {
              "key": "Total Investments Fair Value",
              "value": "$541 million"
            },
            {
              "key": "Current Assets Classification",
              "value": "$103 million"
            },
            {
              "key": "Investments Level 2 Amount",
              "value": "$416 million"
            },
            {
              "key": "Investments Net Value",
              "value": "$438 million"
            },
            {
              "key": "Interest Rate Swap Liability Fair Value",
              "value": "$8 million (Level 2)"
            },
            {
              "key": "Table Title 2",
              "value": "Debt Structure and Maturity Analysis"
            },
            {
              "key": "Estimated Fair Value of Long-Term Debt (2021)",
              "value": "$38.541 billion"
            },
            {
              "key": "Carrying Amount of Long-Term Debt (2021)",
              "value": "$34.827 billion"
            },
            {
              "key": "Senior Secured Asset-Based Revolving Credit Facility (Current)",
              "value": "$2,900 million (effective interest rate 5.6%)"
            },
            {
              "key": "Senior Secured Term Loan Facilities (Current)",
              "value": "$1,880 million (effective interest rate 5.9%)"
            },
            {
              "key": "Senior Secured Notes / Other Senior Secured Debt (Current)",
              "value": "$953 million"
            },
            {
              "key": "Senior Secured Debt (Previous)",
              "value": "$21,875 million (no current period value reported)"
            },
            {
              "key": "Senior Unsecured Notes (Current)",
              "value": "$32,652 million"
            },
            {
              "key": "Debt Issuance Costs and Discounts (Current)",
              "value": "-$301 million"
            },
            {
              "key": "Total Debt (Current)",
              "value": "$38,084 million (average life 9.6 years, rates averaging 5.0%)"
            },
            {
              "key": "Amounts Due Within One Year (Current)",
              "value": "$370 million"
            },
            {
              "key": "New Senior Notes Issued in 2022",
              "value": "$6,000 million aggregate principal amount (various maturities and rates)"
            },
            {
              "key": "Debt Retirement Pretax Loss",
              "value": "$78 million"
            },
            {
              "key": "Credit Rating Update",
              "value": "S&P issued an investment grade rating; Moody's upgrade in 2021 led to release of subsidiary guarantees and collateral for senior secured notes"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "capital_structure",
          "page": 119,
          "title": "Long-term Debt Overview",
          "data": [
            {
              "key": "Total Senior Secured Credit Facilities",
              "value": "$4.500 billion"
            },
            {
              "key": "Outstanding Loans as of December 31, 2022",
              "value": "$2.900 billion"
            },
            {
              "key": "Asset-based revolving credit facility due date",
              "value": "June 30, 2026"
            },
            {
              "key": "Senior Secured Revolving Credit Facility",
              "value": "$2.000 billion"
            },
            {
              "key": "Senior Secured Term Loan A Facility",
              "value": "$1.388 billion"
            },
            {
              "key": "Senior Secured Term Loan B Facility",
              "value": "$492 million"
            },
            {
              "key": "Availability Increase in January 2023",
              "value": "$1.500 billion"
            },
            {
              "key": "Total Senior Unsecured Notes Principal Amount",
              "value": "$31.791 billion"
            },
            {
              "key": "Medium-term notes amount",
              "value": "$125 million"
            },
            {
              "key": "Debentures amount",
              "value": "$736 million"
            },
            {
              "key": "Long-term Debt Maturities (2024-2027)",
              "value": "$2.382 billion, $4.656 billion, $5.316 billion, $2.396 billion"
            }
          ],
          "currency": "USD"
        }
      ]
    },
    "mentions_new_risk_factors": {
      "value": true,
      "elements": [
        {
          "type": "risk_factor",
          "page": 12,
          "title": "Summary Risk Factors",
          "data": [
            {
              "key": "COVID-19 Risks",
              "value": "Operations affected by COVID-19; potential adverse impacts due to economic and public health conditions; uncertainties regarding the effects of stimulus legislation such as the CARES Act and future pandemics."
            },
            {
              "key": "Indebtedness",
              "value": "High leverage and substantial debt could limit the ability to raise additional capital, pose cash flow challenges, and expose the company to interest rate risks and restrictive debt covenants."
            },
            {
              "key": "Human Capital",
              "value": "Risks related to competition for staffing, shortage of experienced healthcare professionals, particularly nurses and physicians, and challenges in recruiting and retaining key management."
            },
            {
              "key": "Technology and Cybersecurity",
              "value": "Potential cybersecurity incidents or data breaches that could compromise facilities and confidential information, leading to litigation, remediation costs, and disruption of operations."
            },
            {
              "key": "Government Regulation and Legal",
              "value": "Risks arising from health care reform efforts and regulatory changes which may adversely affect business operations and results."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 23,
          "title": "Managed Care and Other Discounted Plans",
          "data": [
            {
              "key": "Managed Care Reimbursement Rates",
              "value": "Admissions reimbursed by managed care and other insurers were 30% for 2022, 31% for 2021, and 29% for 2020."
            },
            {
              "key": "Contract Duration",
              "value": "Managed care contracts are typically negotiated for terms between one and three years."
            },
            {
              "key": "Future Payment Increases Uncertainty",
              "value": "Although annual increases in payment rates have been received, there is no assurance that such increases will continue in the future."
            },
            {
              "key": "Price Transparency Initiatives",
              "value": "Mandatory publication of standard charges and negotiated rates may impact negotiations with payers."
            },
            {
              "key": "No Surprises Act Impact",
              "value": "Requires good faith estimates for uninsured and self-pay patients, with deferred enforcement and potential for patient-provider dispute resolution."
            },
            {
              "key": "Uninsured and Self-Pay Segment",
              "value": "Collection challenges noted; approximately 85% of uninsured patient admissions in 2022 occurred through emergency rooms under EMTALA requirements."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 26,
          "title": "Regulatory Constraints Impacting Capital Expansion and Competition",
          "data": [
            {
              "key": "Overview",
              "value": "State certificate of need (CON) laws and other state approval requirements limit health care facilities' ability to expand services, construct new facilities, or make significant capital expenditures."
            },
            {
              "key": "Impact on Competition",
              "value": "These regulations may restrict competition by impeding new facility entry and service expansion; removal of such requirements could lower barriers and increase competitive activity."
            },
            {
              "key": "Regulatory and Licensing Risks",
              "value": "The document highlights challenges related to licensure, certification, accreditation, and compliance with various federal, state, and local regulations, including the risk of losing Medicare/Medicaid certifications and potential penalties for non-compliance."
            },
            {
              "key": "Management Response",
              "value": "To address these challenges, the organization plans to expand or update its facilities, acquire or construct new facilities, and enhance service offerings, while navigating regulatory constraints."
            },
            {
              "key": "Additional Considerations",
              "value": "The text also mentions specific regulations such as the '36 Month Rule' affecting Medicare billing privileges and emphasizes ongoing challenges such as rising costs and competitive pressures from third-party payer requirements."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 33,
          "title": "Healthcare Reform and Economic Impacts",
          "data": [
            {
              "key": "Annual Open Enrollment Period",
              "value": "Extended for federal marketplaces"
            },
            {
              "key": "Impact of Medicaid Expansion",
              "value": "Varies by state, with some states opting out"
            },
            {
              "key": "No Surprises Act",
              "value": "Prohibits balance billing and requires good faith estimates"
            },
            {
              "key": "IDR Process",
              "value": "Independent dispute resolution for payment disputes"
            },
            {
              "key": "Transparency Initiatives",
              "value": "Includes CMS Care Compare website and insurance charge publication"
            },
            {
              "key": "Economic Impact of COVID-19",
              "value": "Adverse impact on healthcare spending and conditions"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 34,
          "title": "Risk Factors and Regulatory Compliance Overview",
          "data": [
            {
              "key": "Healthcare Payment Programs",
              "value": "Medicare, Medicaid and similar programs are significant payer sources; pressures expected from federal deficit, growing expenditures and aging population."
            },
            {
              "key": "Economic Weakness Risks",
              "value": "Risks during economic downturn include declines in managed care coverage, postponement or cancellation of elective procedures, and increased difficulties collecting patient receivables."
            },
            {
              "key": "Compliance Program",
              "value": "Comprehensive ethics and compliance program with annual training, designed to meet/exceed federal guidelines and industry standards."
            },
            {
              "key": "Antitrust Laws",
              "value": "Discussion of federal and state antitrust laws prohibiting anti-competitive practices, with emphasis on compliance especially in hospital and physician practice acquisitions."
            },
            {
              "key": "Environmental Matters",
              "value": "Subject to environmental regulations; potential increased costs due to greenhouse gas emissions regulations and related compliance measures."
            },
            {
              "key": "Environmental Strategy",
              "value": "Plan to reduce scope 1 and scope 2 greenhouse gas emissions by 2030 in line with the Paris Agreement, including capital investments, renewable energy initiatives, and TCFD reporting."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 42,
          "title": "Risk Factors Related to Regulatory Changes and COVID-19 Impact",
          "data": [
            {
              "key": "Sequestration Adjustment",
              "value": "Adjustment was phased back in with a 1% reduction beginning April 1, 2022, and returned to 2% on July 1, 2022."
            },
            {
              "key": "Extended Sequestration",
              "value": "The BCA sequestration has been extended through the first six months of 2032."
            },
            {
              "key": "Additional Medicare Payment Reduction",
              "value": "An additional Medicare payment reduction of up to 4% was required to take effect in January 2022 due to a mandated sequestration under the PAYGO Act, but its implementation has been delayed until 2025."
            },
            {
              "key": "Government Measures and Telehealth",
              "value": "Federal and state governments have enacted legislation, regulations, and waivers to expand access to telehealth services and ease regulatory burdens on health care providers, alongside other flexibilities related to COVID-19."
            },
            {
              "key": "COVID-19 Public Health Emergency",
              "value": "Temporary measures and flexibilities related to COVID-19, including modifications in value-based care programs, are subject to change as the PHE declared by HHS expires May 11, 2023; the termination of the PHE may impact operations and financial results."
            },
            {
              "key": "Indebtedness Risk",
              "value": "High leverage (total indebtedness of $38.084 billion as of December 31, 2022) and reliance on credit facilities increase vulnerability to economic downturns and potential adverse impacts on financial condition."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 43,
          "title": "Risk Factors Relating to Indebtedness and Financial Flexibility",
          "data": [
            {
              "key": "Increased Interest Rates Risk",
              "value": "Exposing us to the risk of increased interest rates on existing borrowings that are at variable rates."
            },
            {
              "key": "Limitation on Strategic Acquisitions",
              "value": "Limiting our ability to make strategic acquisitions or causing us to make nonstrategic divestitures."
            },
            {
              "key": "Financing Limitations",
              "value": "Limiting our ability to obtain additional financing for various purposes including capital expenditures and acquisitions."
            },
            {
              "key": "Cash Flow Adequacy",
              "value": "May not generate sufficient cash to service all indebtedness."
            },
            {
              "key": "Subsidiary Repayments",
              "value": "Repayment depends on subsidiaries maintaining cash flows."
            },
            {
              "key": "Refinancing Challenges",
              "value": "May find it necessary to refinance indebtedness under unfavorable terms."
            },
            {
              "key": "Covenants Restrictions",
              "value": "Debt agreements contain restrictions that limit operational flexibility."
            },
            {
              "key": "Liquidity Problems",
              "value": "Faced with potential liquidity problems if operating results and cash are insufficient."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 44,
          "title": "Asset-Based Revolving Credit Facility and Human Capital Risks",
          "data": [
            {
              "key": "Borrowing Base",
              "value": "85% of eligible accounts receivable less customary reserves"
            },
            {
              "key": "Liquidity Access",
              "value": "Reduction in borrowing base reduces ability to access the credit facility as a source of liquidity"
            },
            {
              "key": "Event of Default",
              "value": "Payment or bankruptcy event of default may trigger transfer of funds to prepay loans and collateralize letters of credit"
            },
            {
              "key": "Financial Covenant Risk",
              "value": "Failure to meet and maintain specified financial ratios under senior secured credit facilities could lead to an event of default"
            },
            {
              "key": "Collateral Risk",
              "value": "Acceleration of repayment could jeopardize repayment if insufficient assets are available"
            },
            {
              "key": "Human Capital Risk",
              "value": "Labor shortages, competition for staffing, increased costs, and impact of COVID-19 on workforce availability and labor costs"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 45,
          "title": "Operational and Cybersecurity Risk Factors",
          "data": [
            {
              "key": "Recruitment and Retention Risk",
              "value": "Failure to attract, hire, develop, motivate, and retain highly qualified physicians and other personnel could disrupt operations and adversely affect business performance and growth prospects."
            },
            {
              "key": "Succession Planning Risk",
              "value": "Inadequate development and implementation of a succession plan for the management team may lead to operational disruptions."
            },
            {
              "key": "Cybersecurity and Data Privacy Risk",
              "value": "A cybersecurity incident or data breach could compromise sensitive data, including patient and proprietary information, leading to potential litigation, regulatory inquiries, and reputational damage."
            },
            {
              "key": "Technological Vulnerabilities Risk",
              "value": "Reliance on advanced technology systems, including EHRs and medical devices, exposes the organization to risks from software vulnerabilities, cyberattacks, and possible hardware or system design defects."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 46,
          "title": "Cybersecurity and Information Systems Risk Factors",
          "data": [
            {
              "key": "Cybersecurity Costs",
              "value": "Costs associated with remediating the effects of cybersecurity incidents."
            },
            {
              "key": "Impact on Consumer Confidence",
              "value": "Shaken consumer confidence in personal information integrity due to cyberattacks."
            },
            {
              "key": "Significant Resources",
              "value": "Potential need for significant additional resources to enhance protective measures."
            },
            {
              "key": "Insurance Limitations",
              "value": "Insurance coverage may be insufficient to cover all losses from cyber risks."
            },
            {
              "key": "Consequences of Cyber Events",
              "value": "Possible harm to patients, business interruptions, data loss, litigation, reputational damage."
            },
            {
              "key": "Dependence on Information Systems",
              "value": "Critical operations rely on performance of information systems."
            },
            {
              "key": "Vulnerabilities and Threats",
              "value": "Information systems may be vulnerable to damage from various sources."
            },
            {
              "key": "Third-Party Technology Risks",
              "value": "Dependence on third-party platforms increases complexity and potential operational disruption."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 47,
          "title": "Risks of Health Care Technology Initiatives and Regulatory Changes",
          "data": [
            {
              "key": "Health care technology initiatives",
              "value": "Sharing patient data and interoperability measures may adversely affect operations and require significant infrastructure investments."
            },
            {
              "key": "Federal regulatory programs",
              "value": "Government efforts such as the Promoting Interoperability Programs encourage the adoption of certified EHR technology with associated compliance obligations."
            },
            {
              "key": "Compliance risks",
              "value": "Failure to demonstrate meaningful use of certified EHR technology can lead to reduced Medicare payments, financial penalties, or other disincentives."
            },
            {
              "key": "Legislative and regulatory changes",
              "value": "Uncertainty surrounding reforms like the Affordable Care Act, ARPA-enhanced subsidies, and the Inflation Reduction Act, as well as potential new reforms, may impact reimbursement and operational strategies."
            },
            {
              "key": "Operational and financial impact",
              "value": "High cost of new technologies combined with uncertain reimbursements could adversely affect financial performance and operational effectiveness."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 49,
          "title": "Healthcare Regulatory and Compliance Risk Factors",
          "data": [
            {
              "key": "Medicaid Program Changes",
              "value": "Previous requirements to condition Medicaid enrollment on work or community engagement have been rescinded. A federal court is now permitting Georgia to impose such requirements under a Medicaid demonstration program expected to launch in mid-2023."
            },
            {
              "key": "Block Grant Funding",
              "value": "The federal government is reexamining block grant funding structures."
            },
            {
              "key": "Healthcare Reform and Regulation",
              "value": "Current or future health care reform, deficit reduction efforts, and changes in laws or regulations related to government health care programs could materially adversely affect financial position and results of operations."
            },
            {
              "key": "Compliance and Legal Risks",
              "value": "Extensive healthcare laws and regulations (billing practices, patient eligibility, safe harbor provisions, Anti-kickback Statute, EKRA, Stark Law, FCA, No Surprises Act, etc.) require strict compliance; failures could lead to penalties or forced operational changes."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 51,
          "title": "Regulatory and Legal Risk Factors",
          "data": [
            {
              "key": "Jurisdiction",
              "value": "United Kingdom operations and various jurisdictions"
            },
            {
              "key": "Risk Focus",
              "value": "Compliance with evolving laws on privacy, data protection, and information security, particularly in SMS texting practices"
            },
            {
              "key": "Key Regulation",
              "value": "Telephone Consumer Protection Act (TCPA) and associated regulatory guidance"
            },
            {
              "key": "Additional Regulatory Areas",
              "value": "Consumer debt collection, credit reporting (Fair Debt Collection Practices Act, Fair Credit Reporting Act), environmental regulations, and facility construction/expansion (CON laws)"
            },
            {
              "key": "Potential Consequences",
              "value": "Civil penalties, costly compliance responses, litigation, adverse publicity, operational delays, increased costs, and reputational damage"
            },
            {
              "key": "Operational Impact",
              "value": "Non-compliance may subject the company to audits, enforcement actions, and require changes in business practices, capital expenditure programs, and operational expenses"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 53,
          "title": "Risk Factors: Pricing Transparency, Competition, and Uncompensated Care",
          "data": [
            {
              "key": "Quality Measures Impact",
              "value": "Hospitals and other provider types achieving poor quality or lower patient satisfaction scores compared to competitors may negatively affect their competitive position."
            },
            {
              "key": "Price Transparency Requirements",
              "value": "New regulations require hospitals to publish standard charges and provide online price estimators, with additional requirements under the No Surprises Act affecting both insured and uninsured patients."
            },
            {
              "key": "Competitive Environment",
              "value": "Increasing competition from freestanding specialty hospitals, outpatient centers, and consolidated not-for-profit entities, along with physician alignment and vertical integration strategies by payers, may pressure pricing and market share."
            },
            {
              "key": "Uncompensated Care and Collection Risks",
              "value": "There are significant risks associated with rising volumes of uninsured patients and the deterioration of receivables, highlighted by recorded implicit price concessions and substantial uncompensated care costs."
            },
            {
              "key": "Regulatory and Market Consolidation",
              "value": "Ongoing regulatory changes and market consolidation, including changes in licensure, capital expenditure capabilities, and removal of CON requirements in some states, may further impact competitive positioning."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 54,
          "title": "Risk Factors Affecting Healthcare Operations and Revenue",
          "data": [
            {
              "key": "unemployment_levels",
              "value": "Increased unemployment and underemployment rates may adversely affect revenue and patient volumes."
            },
            {
              "key": "legislative_regulatory_changes",
              "value": "Changes such as the elimination of the financial penalty under the ACA and modifications to Medicaid expansion may impact insurance uptake and coverage scope."
            },
            {
              "key": "patient_responsibility_collection",
              "value": "The ability to collect patient responsibility accounts is limited by statutory, regulatory, and investigatory initiatives including litigation concerning billing practices."
            },
            {
              "key": "no_surprises_act_impact",
              "value": "Requirements under the No Surprises Act, including providing good faith estimates and publishing negotiated charges, could affect billing practices and dispute resolutions."
            },
            {
              "key": "third_party_payer_negotiations",
              "value": "Dependence on retaining and negotiating favorable contracts with private third-party payers is critical, with trends toward discounted fee structures and network limitations increasing risks."
            },
            {
              "key": "competitive_pressure_and_economic_factors",
              "value": "Broader economic pressures, including inflation, reduced consumer spending, and competitive dynamics from cost-reduction strategies by large employers, may further impact revenue."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 56,
          "title": "Risk Factors: Acquisition Integration, Regulatory, Climate Change, and ESG Risks",
          "data": [
            {
              "key": "Integration Challenges",
              "value": "Difficulties in timely integration of acquired hospitals and healthcare businesses, including delays in implementing operating procedures and systems."
            },
            {
              "key": "Contingent Liabilities",
              "value": "Potential unknown or contingent liabilities related to acquisitions, such as non-compliance with health care laws, professional liabilities, workers’ compensation, and tax liabilities."
            },
            {
              "key": "Geographic Concentration",
              "value": "High concentration of facilities in Florida and Texas, making the business sensitive to regional regulatory, economic, and public health conditions."
            },
            {
              "key": "Climate Change and Natural Disasters",
              "value": "Risks from hurricanes and other natural disasters, exacerbated by climate change, which could disrupt operations and lead to inadequate insurance coverage."
            },
            {
              "key": "ESG Risks",
              "value": "Challenges in achieving ESG goals and stakeholder expectations, potentially leading to reputational harm and increased regulatory scrutiny."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "risk_factor",
          "page": 58,
          "title": "Value-Based Care Transition and Macroeconomic Risk Factors",
          "data": [
            {
              "key": "Report Issuance",
              "value": "Issued in 2021 and updated in 2022"
            },
            {
              "key": "CMS Innovation Center Initiative",
              "value": "Accelerate the move to value-based care and drive broader system transformation"
            },
            {
              "key": "2030 Goal",
              "value": "Ensure all fee-for-service Medicare beneficiaries and most Medicaid beneficiaries are in an accountable care relationship"
            },
            {
              "key": "Payment Models",
              "value": "Intent to streamline payment models and increase provider participation through mandatory models"
            },
            {
              "key": "State and Private Payer Actions",
              "value": "States aligning quality metrics and private payers requiring quality data reporting and altering reimbursement for preventable adverse events"
            },
            {
              "key": "Risk Disclosures - Quality and Reimbursement",
              "value": "Risks include failure to meet quality standards, lower performance relative to competitors, potential reduced reimbursements, possible repayments to payers, and negative impacts on reputation"
            },
            {
              "key": "Macroeconomic Risks",
              "value": "Adverse impacts from COVID-19, federal deficits, inflation, and changes in economic conditions affecting patient volumes and scheduled procedures"
            },
            {
              "key": "Market Risk",
              "value": "Exposure to market volatility, illiquidity of investment securities held by insurance subsidiaries, with reported figures of $473 million in investments and $38 million unrealized losses"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "risk_factor",
          "page": 77,
          "title": "Market Risk Related to Interest Rates and Tax Examinations",
          "data": [
            {
              "key": "Interest Rate Exposure",
              "value": "Approximately $4.780 billion of long-term debt was subject to variable rates of interest as of December 31, 2022."
            },
            {
              "key": "Fixed Rate Debt",
              "value": "The remaining balance in long-term debt of $33.304 billion was subject to fixed rates as of December 31, 2022."
            },
            {
              "key": "Estimated Fair Value of Long-term Debt",
              "value": "$35.555 billion as of December 31, 2022."
            },
            {
              "key": "Potential Earnings Reduction",
              "value": "A hypothetical 1% increase in interest rates could reduce future pretax earnings by approximately $48 million."
            },
            {
              "key": "Currency Translation Risk",
              "value": "The company does not consider the market risk related to foreign currency translation to be material."
            },
            {
              "key": "IRS Tax Examination",
              "value": "Currently under examination for 2016-2019 tax returns, management believes reporting was done correctly."
            },
            {
              "key": "Material Adverse Effect of Tax Issues",
              "value": "Final resolutions of tax examination disputes could adversely affect results of operations if exceeds recorded estimates."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "risk_factor",
          "page": 100,
          "title": "Audit Internal Controls and Reserve Estimation Process",
          "data": [
            {
              "key": "Audit Procedure Description",
              "value": "Tested management’s internal controls addressing the risks of material misstatement in the Company’s professional liability claims reserves estimation process. Procedures included reviewing the actuarial methodology, significant assumptions, completeness and accuracy of claims data, analyzing insurance contracts by policy year, and assessment of self-insured limits, deductibles and coverage limits."
            },
            {
              "key": "Actuarial Assessment",
              "value": "Involved actuarial specialists to assess valuation methodologies, test significant assumptions, compare historical reserve estimates and develop an independent range of reserves."
            },
            {
              "key": "Auditor",
              "value": "Ernst & Young LLP"
            },
            {
              "key": "Audit Tenure",
              "value": "Served as the Company’s auditor since 1994"
            },
            {
              "key": "Location and Date",
              "value": "Nashville, Tennessee; February 17, 2023"
            },
            {
              "key": "Document Reference",
              "value": "F-4"
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_guidance_updates": {
      "value": true,
      "elements": [
        {
          "type": "guidance_update",
          "page": 10,
          "title": "Business Overview and Strategy of HCA Healthcare, Inc.",
          "data": [
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Total Hospitals Operated",
              "value": "182"
            },
            {
              "key": "States of Operation",
              "value": "20 states and England"
            },
            {
              "key": "Primary Objective",
              "value": "Provide a comprehensive array of quality health care services in the most cost-effective manner possible."
            },
            {
              "key": "Common Stock Exchange",
              "value": "New York Stock Exchange"
            },
            {
              "key": "Stock Symbol",
              "value": "HCA"
            },
            {
              "key": "Incorporated Year",
              "value": "October 2010"
            },
            {
              "key": "Principal Executive Offices",
              "value": "One Park Plaza, Nashville, Tennessee 37203"
            },
            {
              "key": "Available Information",
              "value": "Annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K."
            },
            {
              "key": "Website",
              "value": "www.hcahealthcare.com"
            },
            {
              "key": "Business Strategy",
              "value": "Committed to providing high quality, convenient, and cost-effective health care while growing the business and creating long-term value for stockholders."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "guidance_update",
          "page": 17,
          "title": "Guidance on Healthcare Payment Systems",
          "data": [
            {
              "key": "IRF classification criteria",
              "value": "At least 60% of a facility’s inpatients must have required intensive rehabilitation services for one or more of 13 specified conditions."
            },
            {
              "key": "Improving Medicare Post-Acute Care Transformation Act",
              "value": "Mandates a unified payment system for post-acute care services."
            },
            {
              "key": "IPF PPS payment increase FY 2023",
              "value": "Estimated increase of 3.8%, reflecting a market basket increase of 4.1%."
            },
            {
              "key": "ASC reimbursement system",
              "value": "Reimbursed using a predetermined fee schedule and updated based on hospital market basket index."
            },
            {
              "key": "CMS rate increases FY 2023 for ASCs",
              "value": "Increased by 3.8%, reflecting a market basket increase with a negative productivity adjustment."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "guidance_update",
          "page": 25,
          "title": "Competitive Position Challenges",
          "data": [
            {
              "key": "Competition Strengths",
              "value": "Competing facilities are more established, including tax-supported government agencies and not-for-profit entities."
            },
            {
              "key": "Capital Expenditure Advantage",
              "value": "Tax exemptions and contributions give these entities a funding advantage for capital expenditures."
            },
            {
              "key": "Specialized Services",
              "value": "Large teaching hospitals provide specialized equipment and services unavailable at most hospitals."
            },
            {
              "key": "Market Competition",
              "value": "Compete with specialty hospitals and freestanding ASCs for high margin services."
            },
            {
              "key": "Psychiatric Hospital Competition",
              "value": "Attract patients from wider areas, facing local and regional hospital competition."
            },
            {
              "key": "Transparency Trends",
              "value": "Trends in clinical pricing transparency may impact competitive positions."
            },
            {
              "key": "CMS Requirements",
              "value": "Hospitals must publish standard charges and offer price estimator tools."
            },
            {
              "key": "Regulatory Compliance",
              "value": "Civil monetary penalties may be imposed for noncompliance with price transparency."
            },
            {
              "key": "Insurance Transparency",
              "value": "Health insurers must publish negotiated charges for services."
            },
            {
              "key": "No Surprises Act",
              "value": "Introduces additional transparency requirements for uninsured and self-pay patients."
            },
            {
              "key": "Retaining Physicians",
              "value": "Number and quality of affiliated physicians greatly impact competitive position."
            },
            {
              "key": "Negotiation Strategies",
              "value": "Ability to negotiate service contracts with health service group purchasers is crucial."
            },
            {
              "key": "Managed Care Influence",
              "value": "Managed care plans attempt to control healthcare costs through discounts."
            },
            {
              "key": "Future Success Factors",
              "value": "Retaining and renewing contracts with third-party payers is key for future success."
            },
            {
              "key": "Market Variation",
              "value": "Importance of service contracts varies by community."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "guidance_update",
          "page": 63,
          "title": "Management's Discussion and Analysis of Financial Condition and Results of Operations",
          "data": [
            {
              "key": "document_title",
              "value": "HCA HEALTHCARE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS"
            },
            {
              "key": "report_type",
              "value": "10-K"
            },
            {
              "key": "forward_looking_statements",
              "value": "包含未来展望的声明，包括预期基于股票的报酬费用、预期的资本支出、预期的股息、预期的股份回购等"
            },
            {
              "key": "risk_factors",
              "value": "包括COVID-19影响、立法变更、 Medicare、 Medicaid及其他补偿政策的变化等多种因素影响"
            },
            {
              "key": "key_information",
              "value": "预计的财务状况、运营结果和现金流, 需要与随附的合并财务报表共同阅读。"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "guidance_update",
          "page": 80,
          "title": "Changes in Internal Control Over Financial Reporting",
          "data": [
            {
              "key": "Period",
              "value": "Fourth quarter of 2022"
            },
            {
              "key": "Changes",
              "value": "No changes in internal control over financial reporting that materially affected or are reasonably likely to materially affect internal control over financial reporting."
            },
            {
              "key": "Item 9B",
              "value": "Other Information: None"
            },
            {
              "key": "Disclosure Regarding Foreign Jurisdictions",
              "value": "None."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "guidance_update",
          "page": 115,
          "title": "Assets and Liabilities Breakdown",
          "data": [
            {
              "key": "Total Assets (2022)",
              "value": "$2,187 million"
            },
            {
              "key": "Total Assets (2021)",
              "value": "$2,203 million"
            },
            {
              "key": "Total Liabilities (2022)",
              "value": "$2,074 million"
            },
            {
              "key": "Total Liabilities (2021)",
              "value": "$1,808 million"
            },
            {
              "key": "Federal Net Operating Loss Carryforwards",
              "value": "$28 million"
            },
            {
              "key": "State Net Operating Loss Carryforwards",
              "value": "$193 million"
            },
            {
              "key": "Unrecognized Tax Benefits (2022)",
              "value": "$278 million"
            },
            {
              "key": "Unrecognized Tax Benefits (2021)",
              "value": "$217 million"
            },
            {
              "key": "Accrued Interest (2022)",
              "value": "$129 million"
            },
            {
              "key": "Accrued Interest (2021)",
              "value": "$99 million"
            }
          ],
          "currency": "USD"
        },
        {
          "type": "guidance_update",
          "page": 130,
          "title": "Forward-Looking Statements",
          "data": [
            {
              "key": "Company",
              "value": "HCA Healthcare, Inc."
            },
            {
              "key": "Context",
              "value": "This document contains forward-looking statements within the meaning of federal securities laws."
            },
            {
              "key": "Implications",
              "value": "These forward-looking statements are based on current plans and expectations."
            },
            {
              "key": "Risks",
              "value": "Subject to a number of known and unknown uncertainties and risks."
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_regulatory_or_litigation_issues": {
      "value": true,
      "elements": [
        {
          "type": "regulatory_litigation",
          "page": 13,
          "title": "Regulatory Risks and Litigation",
          "data": [
            {
              "key": "Changes in government health care programs",
              "value": "may adversely affect our revenues"
            },
            {
              "key": "Failure to comply with laws",
              "value": "could suffer penalties or be required to make significant changes to our operations"
            },
            {
              "key": "State regulation effects",
              "value": "could impair our ability to operate and expand operations"
            },
            {
              "key": "Potential additional tax liabilities",
              "value": "may incur additional tax liabilities"
            },
            {
              "key": "Government investigations",
              "value": "have been and could become the subject of various investigations, claims and litigation"
            },
            {
              "key": "Liability risks",
              "value": "may be subject to liabilities from claims against our facilities"
            },
            {
              "key": "Competition risks",
              "value": "face competition for patients from other hospitals and health care providers"
            },
            {
              "key": "Impact of uninsured patients",
              "value": "increased volume of uninsured patients could adversely affect results"
            },
            {
              "key": "Dependence on private insurance",
              "value": "may decline or inability to retain contracts could affect revenues"
            },
            {
              "key": "External factors impact",
              "value": "demand for medical services may reduce revenues"
            },
            {
              "key": "Acquisition risks",
              "value": "difficulties acquiring hospitals and unknown liabilities may arise"
            },
            {
              "key": "Concentration in Florida and Texas",
              "value": "sensitive to changes in regulatory, economic, competitive conditions in those states"
            },
            {
              "key": "Climate change risks",
              "value": "subject to risks related to climate change and achievements of ESG goals"
            },
            {
              "key": "Market risks",
              "value": "exposed to market risk related to changes in securities and interest rates"
            },
            {
              "key": "Dividend assurance",
              "value": "no assurance that we will continue to pay dividends"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 21,
          "title": "Federal Medicaid Program Challenges and Changes",
          "data": [
            {
              "key": "Texas Healthcare Transformation Program",
              "value": "Operated under a Medicaid waiver, expands Medicaid managed care programs, provides funding for uncompensated care."
            },
            {
              "key": "Future Program Extensions",
              "value": "Texas waiver extended through 2030, but uncertainty exists for future extensions."
            },
            {
              "key": "Legal Challenges",
              "value": "Past aspects of Medicaid waivers are subject to legal challenges."
            },
            {
              "key": "Federal Policy Changes",
              "value": "Federal policies affecting Medicaid programs are subject to change with new administration."
            },
            {
              "key": "Value-Based Purchasing",
              "value": "Incorporates models incentivizing improvements in quality and cost-effectiveness."
            },
            {
              "key": "Fraud Prevention",
              "value": "Congress expanded federal involvement to combat fraud, waste, and abuse in Medicaid."
            },
            {
              "key": "Accountable Care Organizations (ACOs)",
              "value": "Networks aimed at improving service delivery and quality."
            },
            {
              "key": "Bundled Payment Initiatives",
              "value": "One payment for services tied to quality and cost efficiency."
            },
            {
              "key": "Pass-Through Payments",
              "value": "States are limited on supplemental payments under managed Medicaid plans."
            },
            {
              "key": "CMS Innovation Center",
              "value": "Responsible for demonstration projects in Medicare and Medicaid."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 22,
          "title": "CMS Payment Model Updates and Pending Litigation Impact",
          "data": [
            {
              "key": "CMS Mandatory Models",
              "value": "Providers in selected geographic areas are required to participate in a mandatory bundled program for specified orthopedic procedures and a model for end-stage renal disease treatment; a mandatory radiation oncology model was expected to start on January 1, 2023 but has been indefinitely delayed with a six months notice provision."
            },
            {
              "key": "CMS Innovation Strategy",
              "value": "The CMS Innovation Center highlights accelerating the move to value-based care, aiming that by 2030 all fee-for-service Medicare beneficiaries and most Medicaid beneficiaries are in accountable care relationships, with plans to streamline payment models and increase care coordination between primary care physicians and specialists."
            },
            {
              "key": "Pending Litigation",
              "value": "There is pending litigation challenging the payment formula for Disproportionate Share Hospital (DSH) payments for prior years and potential future policies, which could affect the calculation of payments and result in either increases or decreases in future reimbursements."
            },
            {
              "key": "Medicaid DSH Changes",
              "value": "Under current law, Medicaid DSH payments will be reduced by $8 billion in each of federal fiscal years 2024 through 2027, with reductions delayed until FY2024; CMS has proposed changes that could lower DSH payments for many hospitals."
            },
            {
              "key": "Supplemental Payments",
              "value": "Hospitals receive supplemental payments separate from base payments through Medicaid and other programs, including upper payment limit payments designed to offset differences between Medicaid fee-for-service payments and Medicare reimbursement rates; these programs are subject to CMS rulemaking."
            },
            {
              "key": "TRICARE Reimbursement",
              "value": "TRICARE reimburses hospitals using a DRG system for inpatient services and a Prospective Payment System for outpatient services, modeled on Medicare's payment frameworks."
            },
            {
              "key": "Annual Cost Reports",
              "value": "Providers must submit annual cost reports covering revenues, costs, and expenses associated with services rendered, subject to audits which may lead to adjustments affecting final payment determinations."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 27,
          "title": "Certificates of Need and Healthcare Regulatory Compliance Overview",
          "data": [
            {
              "key": "Certificates of Need",
              "value": "In some states where the provider operates hospitals and health care facilities, construction, expansion, acquisition, ownership transfer, capital expenditures, and addition of beds or services may require review and approval under a CON program to demonstrate public need."
            },
            {
              "key": "Federal Health Care Program Regulations",
              "value": "Participation in Medicare, Medicaid, and other federal health care programs is heavily regulated. Failure to comply with participation conditions can lead to termination of programs and imposition of civil or criminal penalties, including fines that adjust with the consumer price index."
            },
            {
              "key": "Anti-kickback Statute",
              "value": "The Anti-kickback Statute prohibits providers from soliciting, receiving, or offering remuneration for referrals related to services covered by federal programs. Violations can result in criminal fines, imprisonment, civil penalties, damages, and even exclusion from federal health care programs."
            },
            {
              "key": "OIG Oversight and Incentive Arrangements",
              "value": "The Office of Inspector General (OIG) conducts audits, investigations, and provides guidance (e.g., Special Fraud Alerts) on suspect incentive arrangements in healthcare, encouraging reporting of practices that may violate federal health care laws."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 28,
          "title": "Guidance on Anti-kickback Statute and Stark Law Compliance",
          "data": [
            {
              "key": "Topic",
              "value": "Regulatory Compliance"
            },
            {
              "key": "Key Areas",
              "value": "OIG guidance, Safe harbor regulations, Stark Law"
            },
            {
              "key": "Risk Areas",
              "value": "Compensation arrangements, Recruitment arrangements, Joint venture relationships"
            },
            {
              "key": "Potential Liabilities",
              "value": "Civil monetary penalties, Criminal penalties, Exclusion from Medicare/Medicaid programs"
            },
            {
              "key": "Exceptions",
              "value": "Financial relationships under Stark Law"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 29,
          "title": "Regulatory Compliance and Fraud Provisions under Stark Law",
          "data": [
            {
              "key": "Regulation",
              "value": "CMS has issued final regulations implementing the Stark Law through a series of rulemakings."
            },
            {
              "key": "Interpretation Uncertainty",
              "value": "There is ambiguity regarding how the government will interpret many of the exceptions to the Stark Law."
            },
            {
              "key": "Compliance Challenge",
              "value": "The regulations implementing the exceptions are detailed, complex, and subject to ongoing legal and regulatory changes."
            },
            {
              "key": "Fraud and Abuse Provisions",
              "value": "Federal fraud and abuse laws, including the FCA, Anti-kickback Statute, and EKRA, impose criminal and civil penalties for false claims, billing errors, and other prohibited activities."
            },
            {
              "key": "Penalty Risks",
              "value": "Violations can result in substantial civil monetary penalties, exclusion from federal and state programs, and other severe sanctions."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 30,
          "title": "Regulatory Liability under FCA and HIPAA Compliance",
          "data": [
            {
              "key": "Regulatory Framework",
              "value": "The document discusses liability under the False Claims Act (FCA) and compliance with HIPAA regulations."
            },
            {
              "key": "FCA Liability",
              "value": "Entities may be liable for triple damages plus substantial mandatory civil penalties for each false claim, with penalties updated annually based on the consumer price index."
            },
            {
              "key": "Submission Standards",
              "value": "Not only intentional fraud but also claims submitted with reckless disregard to their truth or falsity constitute a ‘knowing’ submission under the FCA."
            },
            {
              "key": "Additional Liability Factors",
              "value": "Submission of claims in violation of statutes like the Anti-kickback Statute or failure to refund overpayments can trigger liability under the FCA."
            },
            {
              "key": "HIPAA Compliance Requirements",
              "value": "Highlights the HIPAA Administrative Simplification provisions including the use of uniform electronic data standards, National Provider Identifier, and stringent privacy, security, and breach notification requirements."
            },
            {
              "key": "Enforcement and Penalties",
              "value": "Enforcement by HHS and state attorneys general may result in significant criminal and civil penalties for violations of HIPAA and related regulations."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 31,
          "title": "Regulatory and Legislative Environment Overview",
          "data": [
            {
              "key": "Privacy and Security Laws",
              "value": "Discusses federal and state legislative and regulatory initiatives addressing privacy and security concerns, including laws more restrictive than HIPAA and bills such as the CCPA (and its amendments via CPRA), Colorado Privacy Act, Utah Privacy Act, and Virginia Consumer Data Protection Act."
            },
            {
              "key": "Enforcement and Penalties",
              "value": "Highlights enforcement actions by agencies like the Federal Trade Commission and potential penalties such as civil fines, exclusion from Medicare, and other monetary sanctions for non-compliance."
            },
            {
              "key": "Compliance Costs and Practices",
              "value": "Mentions that compliance with these expansive and varying laws may require changes in data processing practices, policies, and incur substantial costs."
            },
            {
              "key": "EMTALA Requirements",
              "value": "Explains EMTALA’s obligations for hospitals regarding emergency screening, stabilization, and transfer requirements, including associated penalties for non-compliance."
            },
            {
              "key": "Corporate Practice of Medicine/Fee Splitting",
              "value": "Notes state laws prohibiting non-physician owned entities from certain practices, with sanctions like loss of license and civil/criminal penalties."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 32,
          "title": "Health Care Industry Investigations",
          "data": [
            {
              "key": "Overview",
              "value": "Significant media and public attention has focused on the hospital industry, leading to increased scrutiny of the health care industry."
            },
            {
              "key": "Investigations",
              "value": "Governmental entities could initiate investigations or litigation, which could result in significant penalties and adverse publicity."
            },
            {
              "key": "Compliance Program",
              "value": "The company has developed a comprehensive ethics and compliance program to meet or exceed federal guidelines."
            },
            {
              "key": "Government Enforcement Focus",
              "value": "Federal and state agencies have increased coordination of civil and criminal enforcement efforts related to health care."
            },
            {
              "key": "Routine Operations Under Scrutiny",
              "value": "Investigations have addressed cost reporting, billing practices, financial arrangements, and patient charging practices."
            },
            {
              "key": "Impact of Health Care Reform",
              "value": "The Affordable Care Act and other reforms are changing industry practices and affecting coverage and reimbursement."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 41,
          "title": "Impact of COVID-19 on Financial Performance and Operations",
          "data": [
            {
              "key": "COVID-19 Impact",
              "value": "Operations and financial performance affected by governmental actions in response to COVID-19."
            },
            {
              "key": "Patient Volumes",
              "value": "Reduced patient volumes due to COVID-19 and may continue to affect future volumes."
            },
            {
              "key": "Telehealth Services",
              "value": "Increased use of telehealth services impacting patient visits."
            },
            {
              "key": "Financial Assistance",
              "value": "Various forms of financial assistance available to health care providers through acts like the CARES Act."
            },
            {
              "key": "Provider Relief Fund",
              "value": "Funding authorized to assist hospitals and health care providers with expenses related to COVID-19."
            },
            {
              "key": "CARES Act",
              "value": "Enable financial relief through hospital payments and reimbursement mechanisms."
            },
            {
              "key": "Repayment of Funds",
              "value": "$6.1 billion returned or repaid early related to Provider Relief Fund distributions."
            },
            {
              "key": "Medicare Adjustments",
              "value": "Increased payments for COVID-19 patients and suspended Medicare sequestration."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "regulatory_litigation",
          "page": 48,
          "title": "Impact of Regulatory Changes on Medicare and Medicaid Programs",
          "data": [
            {
              "key": "Quality Measures Performance",
              "value": "Patient volumes could decline if facilities achieve poor results."
            },
            {
              "key": "Medicare Reimbursement Adjustments",
              "value": "Medicare reimbursement adjusted based on quality and efficiency measures."
            },
            {
              "key": "Impact of Health Care Reform",
              "value": "Changes to the Affordable Care Act may adversely affect operations, cash flow, capital resources, and liquidity."
            },
            {
              "key": "Revenue Dependency",
              "value": "43.6% of revenues derived from Medicare and Medicaid programs in 2022."
            },
            {
              "key": "Payment Reductions Under BCA",
              "value": "Automatic spending reductions resulted in 2% reduction in Medicare payments beginning in 2013."
            },
            {
              "key": "Impact of CARES Act",
              "value": "Temporarily suspended reductions through March 31, 2022 and reduced sequestration adjustment."
            },
            {
              "key": "Future Legislative Changes",
              "value": "Potential for additional Medicare spending reductions from Congress."
            },
            {
              "key": "Changes to Reimbursement Systems",
              "value": "Revisions to payment systems may lead to reduced Medicare payments."
            },
            {
              "key": "State Medicaid Budget Pressures",
              "value": "States may consider legislation to reduce Medicaid expenditures."
            },
            {
              "key": "Federal Policy Changes",
              "value": "Federal Medicaid policies are subject to change with new administration."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 50,
          "title": "Regulatory Compliance Risks",
          "data": [
            {
              "key": "Federal Civil Monetary Penalty Law",
              "value": "Lower burden of proof than other fraud laws"
            },
            {
              "key": "Stark Law Compliance",
              "value": "Required for financial relationships with referring physicians"
            },
            {
              "key": "FDA Regulation of Software",
              "value": "Potential classification as medical devices requiring premarket approval"
            },
            {
              "key": "Foreign Corrupt Practices Act",
              "value": "Regulates bribes and requires accurate record-keeping"
            },
            {
              "key": "California Consumer Privacy Act (CCPA)",
              "value": "Expanded privacy protections for consumers"
            },
            {
              "key": "UK Data Protection Legislation",
              "value": "Stricter privacy laws post-Brexit with significant fines"
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 52,
          "title": "Regulatory and Litigation Risks",
          "data": [
            {
              "key": "Subject",
              "value": "Tax liabilities and compliance issues."
            },
            {
              "key": "Details",
              "value": "Potential for additional tax liabilities due to changes in laws and regulations affecting operations."
            },
            {
              "key": "Government Investigations",
              "value": "Possible government inquiries and investigations related to health care operations."
            },
            {
              "key": "Liabilities",
              "value": "Liabilities from claims, costly to defend, and potential significant damages."
            },
            {
              "key": "Insurance Coverage",
              "value": "Management believes reserves and coverage are sufficient but some claims may exceed limits."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 55,
          "title": "Medicaid and Acquisitions Regulation Analysis",
          "data": [
            {
              "key": "COVID-related legislation",
              "value": "States maintaining continuous Medicaid enrollment until the end of Public Health Emergency (PHE) are eligible for a temporary increase in federal funds."
            },
            {
              "key": "Decoupling Medicaid coverage from PHE",
              "value": "Continuous coverage requirement will expire as of April 1, 2023."
            },
            {
              "key": "Federal funding phase out",
              "value": "Federal funding will be phased out through calendar year 2023."
            },
            {
              "key": "Medicaid redeterminations",
              "value": "May lead to coverage disruptions and dis-enrollments of current Medicaid enrollees."
            },
            {
              "key": "Expansion of Medicaid programs",
              "value": "States may modify Medicaid programs and the terms of expansion."
            },
            {
              "key": "Individual health insurance mandates",
              "value": "Some states impose financial penalties for noncompliance."
            },
            {
              "key": "Public health insurance options",
              "value": "Explored or offered by some states."
            },
            {
              "key": "Impact on uninsured individuals",
              "value": "Difficult to predict number of uninsured due to evolving variables."
            },
            {
              "key": "Changes in service demand",
              "value": "Factors like physician utilization practices and third-party payer controls may reduce revenues."
            },
            {
              "key": "Utilization review",
              "value": "Third-party payer controls affecting admissions and intensity of services."
            },
            {
              "key": "Medicare coverage restrictions",
              "value": "Medicare issues coverage determinations that restrict services."
            },
            {
              "key": "Impact on inpatient utilization",
              "value": "Pre-admission authorization requirements impacting lengths of stay."
            },
            {
              "key": "Cost control efforts",
              "value": "Expected to continue impacting service demand."
            },
            {
              "key": "Health plan design trends",
              "value": "Shift accountability to patients, affecting surgical volumes."
            },
            {
              "key": "External factors impacting volumes",
              "value": "Infectious outbreaks, weather conditions, and technology evolution."
            },
            {
              "key": "In-home care models expansion",
              "value": "May lead to decline in inpatient volumes."
            },
            {
              "key": "Impact of acquisitions",
              "value": "Difficulties in acquiring hospitals and potential liabilities."
            },
            {
              "key": "Competition in acquisitions",
              "value": "Other purchasers may offer higher prices for acquisitions."
            },
            {
              "key": "Antitrust enforcement",
              "value": "Federal Trade Commission prioritizing health care industry enforcement."
            },
            {
              "key": "Certificate of Need (CON) requirements",
              "value": "Some states require CON for hospital acquisitions."
            },
            {
              "key": "Licensure and change of ownership",
              "value": "Acquisitions involve complex regulatory processes."
            },
            {
              "key": "Sale of non-profit hospitals",
              "value": "Laws may restrict conversions or sales to for-profit entities."
            },
            {
              "key": "Attorney General involvement",
              "value": "Oversight often required for non-profit transactions."
            },
            {
              "key": "Regulatory compliance issues",
              "value": "May inhibit acquisition abilities."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 86,
          "title": "Credit Agreements and Exceptions",
          "data": [
            {
              "key": "Document 1",
              "value": "Joinder Agreement and Amendment No. 1, dated as of October 30, 2014."
            },
            {
              "key": "Document 2",
              "value": "Restatement Agreement, dated as of June 28, 2017."
            },
            {
              "key": "Document 3",
              "value": "Joinder Agreement, dated as of January 3, 2018."
            },
            {
              "key": "Document 4",
              "value": "Restatement Agreement, dated as of June 30, 2021."
            },
            {
              "key": "Document 5",
              "value": "Amendment No. 1 to Credit Agreement dated as of January 4, 2023."
            },
            {
              "key": "Document 6",
              "value": "Security Agreement, dated as of September 30, 2011."
            },
            {
              "key": "Document 7",
              "value": "Supplement No. 1, dated as of October 27, 2011."
            },
            {
              "key": "Document 8",
              "value": "General Intercreditor Agreement, dated as of November 17, 2006."
            },
            {
              "key": "Document 9",
              "value": "Receivables Intercreditor Agreement, dated as of November 17, 2006."
            },
            {
              "key": "Document 10",
              "value": "First Lien Intercreditor Agreement, dated as of April 22, 2009."
            },
            {
              "key": "Document 11",
              "value": "Additional General Intercreditor Agreement, dated as of August 1, 2011."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "regulatory_litigation",
          "page": 121,
          "title": "CONTINGENCIES",
          "data": [
            {
              "key": "Description",
              "value": "We operate in a highly regulated and litigious industry, facing various lawsuits, claims and legal/proceedings."
            },
            {
              "key": "Potential Impact",
              "value": "The resolution of lawsuits, claims or legal proceedings could negatively impact operations, financial position or liquidity."
            },
            {
              "key": "Government Investigations",
              "value": "Health care companies are subject to numerous investigations by governmental agencies."
            },
            {
              "key": "FCA Compliance Issues",
              "value": "Private parties can bring qui tam lawsuits against companies submitting false claims."
            },
            {
              "key": "Texas Medicaid Program Investigation",
              "value": "Received requests for information about compliance with laws and regulations under the Texas Medicaid program."
            },
            {
              "key": "Qui Tam Lawsuit",
              "value": "A qui tam lawsuit related to the Program and its operations in Harris County was unsealed."
            },
            {
              "key": "Current Status",
              "value": "The company is defending vigorously against the lawsuit."
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_strategic_restructuring": {
      "value": true,
      "elements": [
        {
          "type": "strategic_restructuring",
          "page": 65,
          "title": "HCA HEALTHCARE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued) Business Strategy",
          "data": [
            {
              "key": "Overview",
              "value": "The document outlines HCA Healthcare's business strategy to provide high quality, convenient and cost‐effective healthcare while growing the business and creating long‐term value for stockholders."
            },
            {
              "key": "Growth Agenda",
              "value": "The strategy is organized around driving sustained growth through expanding presence in existing markets, recruiting and collaborating with physicians, and developing comprehensive service lines including cardiology, neurology, oncology, orthopedics, and women’s services."
            },
            {
              "key": "Operational Excellence",
              "value": "Initiatives to achieve industry-leading performance in patient safety, satisfaction, and clinical quality have been implemented, such as infection reduction initiatives, hospitalist programs, advanced health IT, and evidence-based medicine programs."
            },
            {
              "key": "Human Resources Focus",
              "value": "A critical component of the strategy is recruiting and retaining physicians and other healthcare professionals by providing high quality facilities, advanced technology, and expanded specialty services."
            },
            {
              "key": "Economies of Scale and Cost Efficiency",
              "value": "The company leverages its scale through centralized processes, investments in support infrastructure (e.g., revenue cycle management, supply chain management, staffing functions), and initiatives like care navigators and clinical data exchange to improve cost efficiency and care coordination."
            },
            {
              "key": "Future Development",
              "value": "A disciplined development strategy is being pursued, involving selective development and acquisition of new hospitals, outpatient facilities, and investments in digital capabilities and innovative care models."
            }
          ],
          "currency": "N/A"
        }
      ]
    },
    "has_supply_chain_disruptions": {
      "value": false,
      "elements": []
    },
    "has_esg_initiatives": {
      "value": true,
      "elements": [
        {
          "type": "esg_initiative",
          "page": 6,
          "title": "HCA Healthcare ESG and Community Support Initiatives",
          "data": [
            {
              "key": "Collaboration Partners",
              "value": "HCA Healthcare is collaborating with Johnson & Johnson and other partners such as the HCA Healthcare Foundation, American Heart Association, and Communities Foundation of Texas."
            },
            {
              "key": "Health Equity Initiatives",
              "value": "Focus on improving health outcomes through early-stage lung cancer detection for the Black community, and providing more resources to nurses on health equity issues."
            },
            {
              "key": "Cardiovascular and Stroke Initiatives",
              "value": "Launching 'Getting to the Heart of Stroke' in 15 select markets to prevent initial and recurrent strokes and improve overall stroke care."
            },
            {
              "key": "Disaster Response",
              "value": "Post-Hurricane Ian support in Florida with on-site mini-marts, fuel stations, showers, laundry services, and financial aid through the HCA Healthcare Hope Fund."
            },
            {
              "key": "Community Grants and Investments",
              "value": "Foundation commitments include approximately $1.38 million to Girl Scouts for mental wellness workshops, over $350,000 for Kentucky flood relief, $600,000 to Volunteers of America for first responder support, $250,000 to the American Red Cross for disaster relief, $1.35 million to Educate Texas, $1.5 million investment to Florida International University’s Nicole Wertheim College of Nursing & Health Sciences, and $750,000 to The University of Texas at El Paso to advance diversity in healthcare."
            },
            {
              "key": "ESG Focus",
              "value": "Initiatives aimed at advancing health equity, enhancing patient care, supporting disaster relief efforts, and promoting diversity in healthcare leadership and education."
            }
          ],
          "currency": "USD"
        },
        {
          "type": "esg_initiative",
          "page": 35,
          "title": "Environmental Compliance, Insurance, Human Capital & Diversity, Equity and Inclusion",
          "data": [
            {
              "key": "Environmental Compliance",
              "value": "Compliance with existing environmental laws is currently not material; however, changes such as evolving consumer preferences and new low-carbon legislation could increase operational and compliance costs."
            },
            {
              "key": "Insurance Details",
              "value": "Facilities are insured via an insurance subsidiary with coverage up to $80 million per occurrence (with a $15 million self-insured retention) and additional reinsurance for professional liability. Coverage for cyber security, directors and officers liability, and property loss is obtained from unrelated insurance companies."
            },
            {
              "key": "Human Capital",
              "value": "The workforce consists of approximately 294,000 employees as of December 31, 2022, including around 87,000 part-time/PRN employees."
            },
            {
              "key": "Diversity, Equity and Inclusion (DEI)",
              "value": "The company is committed to DEI with 78% women and 44% people of color. Initiatives include leadership by a Chief Diversity Officer, an Executive Diversity Council, multiple DEI Councils, and several employee resource groups. A DEI strategy launched in early 2020 supports advancing diverse candidates into leadership roles, with additional sponsorship programs initiated in 2022."
            },
            {
              "key": "Corporate Governance and DEI",
              "value": "Corporate Governance Guidelines reinforce the commitment to diversity by ensuring that nominations for board candidates include qualified diverse candidates."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "esg_initiative",
          "page": 36,
          "title": "DEI, Pay Equity and Employee Wellbeing Initiatives",
          "data": [
            {
              "key": "DEI and Pay Equity Programs",
              "value": "Information regarding our DEI and pay equity programs and initiatives is provided, emphasizing commitment to diversity, equity, and inclusion."
            },
            {
              "key": "Compensation and Benefits",
              "value": "Competitive compensation and benefits programs designed to attract, retain, recognize and reward employees. Includes Employee Stock Purchase Plan, 401(k), health care and insurance benefits, flexible spending accounts, paid time off, family leave, flexible work schedules, and wellness programs."
            },
            {
              "key": "Recruitment and Workforce Development",
              "value": "Initiatives to attract and acquire talent including early outreach programs, internships, career paths, and diversity recruitment efforts, as well as investments in community health care programs and addressing workforce shortages."
            },
            {
              "key": "Serving the Community",
              "value": "Efforts to provide quality health care and address community needs through partnerships, research, and investments, including support for non-profit organizations via the HCA Healthcare Foundation."
            },
            {
              "key": "Culture and Talent Development",
              "value": "Programs focusing on employee engagement, leadership development and succession planning through education, training, tuition assistance, student loan payment assistance, and specialized leadership programs."
            },
            {
              "key": "Health, Safety and Wellness",
              "value": "Robust initiatives aimed at supporting the physical, mental, and financial health of employees, including online Wellbeing Hub, Nurse Care help line, and partnerships with Optum Wellbeing Services."
            }
          ],
          "currency": "N/A"
        },
        {
          "type": "esg_initiative",
          "page": 57,
          "title": "ESG Reporting Challenges and Healthcare Payment Risks",
          "data": [
            {
              "key": "ESG Challenges",
              "value": "Evolving standards in ESG reporting and voluntary disclosure frameworks may lead to inconsistent or non-comparable data, affecting goal achievement."
            },
            {
              "key": "Reputational Risk",
              "value": "Inability to meet ESG objectives could result in reputational harm, negative public sentiment, regulatory scrutiny, litigation, and reduced investor confidence."
            },
            {
              "key": "Healthcare Payment Models",
              "value": "Value-based purchasing trends and CMS initiatives such as bundled payment models, quality data reporting, and reimbursement adjustments may impact revenues and operational performance."
            },
            {
              "key": "Regulatory Compliance",
              "value": "Challenges in complying with evolving federal, state, and international ESG-related laws and standards could lead to significant revisions to goals and increased costs."
            }
          ],
          "currency": "N/A"
        }
      ]
    }
  },
  "currency": {
    "USD": 54,
    "EUR": 1,
    "AUD": 46
  },
  "sha1": "a69ebee82a9acd54117407ca3697db0d7bfbfdac"
}